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Abstract 
The medicinal effects ofbetaines have only recently been studied, and this thesis furthers this field. 
Chapter 2 describes the process of developing a betaine assay in order to assay the betaine content 
offoods. The final methods are described in section 2.5. Using those methods, foods commonly 
found the New Zealand diet were assayed and a database of betaine contents in foods can be 
found in chapter 3. Foods that were high in particular betaines have been studied further, to get 
an indication of the variation between food samples that is present. This study found that there 
are only three betaines present in the diet at leyels high enough to have potential metabolic effects: 
glycine betaine, trigonelline and proline betaine. The database has been used to estimate the 
average daily intake of glycine betaine, trigonelline and proline betaine at 150-200, 20 and 15 
mg/day respectively. A diet was also designed to maximize glycine betaine intake, resulting in an 
intake of 620 mg/day. Chapters 4 and 5 describe experiments on the effect of dietary betaines on 
different medical problems. Chapter 4 shows that there is a increase in plasma homocysteine 
concentrations associated with the consumption of coffee, which is consistent with the hypothesis 
that trigonelline in coffee interacts with homocysteine homoeostasis. Trigonelline has some 
antimicrobial properties in certain conditions, and the question of trigonelline in the diet being a 
potential to be utilized in the treatment or prevention of urinary tract infections (UTI) is addressed 
in Chapter 5. Due to a number of factors (discussed in section 5.5), the antimicrobial properties 
of trigonelline have no effect in human urine, and trigonelline is unable to be used to treat or 
prevent UTI. 
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Chapter 1 
Background 
"Anyone who isn't con}ilsed really doesn't understand the situation." 
Edward Murrow 
1.1. Betaines 
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I. Background 
Betaine was the name given to a substance that was isolated and crystalized from beet (Beta 
vulgaris) by Scheibler (1869). This compound proved to be N,N,N-trimethylglycine (figure 1.1), 
now commonly known as glycine betaine. The term betaine is often still used to describe glycine 
betaine, although it is common for betaine to describe glycine betaine or its analogues. For the 
purposes of this thesis, betaines will be defined as analogues of N,N,N-trimethylglycine that have 
a quaternary amino group, bearing a positive charge at all pH, and a carboxylate moiety that has 
a negative charge at physiological pH, giving the compound a nett charge of zero. Also covered 
are compounds that have a positively charged moiety that is not a quaternary amine. For example, 
arsenobetaine, found in seafood has a quaternary arsonium centre, and dimethy Isulfoniopropionate 
(DMSP), found in shellfish, has a tertiary sulfonium centre. 
1.1.1. Distribution and function in nature 
Betaines can be found in all kingdoms of life. The biological roles of betaines are not completely 
.understood, but betaines are involved in cell volume regulation, as methyl donors, in cell to cell 
signalling and as carrier molecules. Some betaines, such as glycine betaine, are accumulated by 
cells, and play important roles in cell volume regulation (sections 1.1.1.1, 1.2.1). Glycine betaine 
can be a source of methyl groups, and is involved in methyl group metabolism (section 1.2.2). 
Carnitine is a betaine that is essential in all eucaryotic cells for the transport of long-chain fatty 
acids across the mitochondrial membrane. The fatty acids are trans-esterified to carnitine (figure 
1.1), and the resultant long-chain acylcarnitine esters are transported into the mitochondria via 
a specific translocase, allowing the metabolism of long-chain fatty acids (reviewed in Rebouche 
1992). The betaines trigonelline and proline betaine are used by legumes as signals to rhizobia, 
initiating the formation of root nodules (Phillips et a1. 1994; Phillips et a1. 1995). Proline betaine 
can also be found in citrus fruits (reviewed in Nolte et al. 1997), and trigonelline in coffee 
(Stennert and Maier 1994), although these betaines have no known fimction in these plants. 
Arsenic is found in sea water as arsenate, and arsenobetaine is believed to be the non-toxic 
metabolic end product of arsenate in marine tlnma (Shibata et al. 1992; Hanaoka et al. 1995). 
Some of these topics are elaborated in the following sections, 
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(CH3~CH:cC06 (CH3JJCHzC~CCO 8 (£L: 8 (CH3}J'JCH:cC~CH.zCOO 
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Figure 1.1: Chemical structures of known betaines that were expected to be found 
in the normal human diet. 
1.1.1.1. Compatible solutes and cell volume regulation 
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I . Background 
A compatible solute is a compound that can be present in high concentrations (> I moll-I) within 
cells without having an adverse effect on cellular components (enzymes, DNA, membranes, etc.) 
or on normal cellular functions (Le Rudulier et aI.1984). Classes of compatible solutes are polyols 
(eg. sorbitol), amino acids (eg. proline) and methyl amines (eg. glycine betaine) (reviewed in 
Somero and Yancey 1997). The concentration of compatible solutes in vitro can be adjusted 
without altering the function of cellular components (Somero and Yancey 1997) and in vivo 
experiments have also shown that cells do better (eg. grow more rapidly) in hyperosmotic media 
when supplied with some compatible solutes (Randall et a1. 1996; Somero and Yancey 1997). 
Changes in cell volume have drastic effects on the concentrations of cell constituents, which 
would have massive metabolic effects. To counter this, some cells have the ability to actively 
accumulate compatible solutes, the effect being that the volume and constituents of the cell (eg. 
water and inorganic salts) remain constant except for the concentration ofthe compatible solute(s) 
(reviewed in Somero and Yancey 1997). The compatible solute(s) used by cells depends on the 
environment and type of cell. For example, Escherichia coli Kl2 synthesizes trehalose after a 
transfer to hyperosmotic medium, unless glycine betaine or proline are present, in which case 
these compatible solutes are accumulated instead (Dinnibier et a!. 1988). Glycine betaine is one 
ofthe most common compatible solutes in nature, and many organisms are able to synthesize or 
selectively accumulate glycine betaine as a means of surviving osmotic changes (Somero and 
Yancey 1997). 
1.1.1.2. Counteracting solutes 
A special class of compatible solutes are counteracting solutes. These solutes have the ability not 
only to be present at high concentrations, but also to reverse the effect of some physical and 
chemical stresses such as heat, urea and alcohol (reviewed in Somero and Yancey 1997). 
Thermodynamic calculations suggest that glycine betaine should be one of the most effective 
counteracting solutes (Timasheff 1992). Counteracting solutes are able to maintain native enzyme 
structures (and other biological macromolecules) in the presence of stresses that would nomlaJly 
denature them. A generally accepted mech~ll1ism tor the action of these solutes is that they [lrc 
preferentially excluded from the surt~H;e of macromolecules, which makes the compact, folded 
tom1 (native) of the macromolecule thermodynamically tU.vourablc (TimushelT 19(3). 
An example of counteracting solutes can be found in the mammalian urinary tract. 
H 
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where invading bacterial cells are frequently subjected to high osmolality and urea concentrations. 
In minimal media, the urea and salt concentrations are often inhibitory to bacterial growth, but 
bacteria are able to colonize the urinary tract. Glycine betaine is present in mammalian urine 
(Lever et al. 1994) and is an important factor in making the urine a suitable growth medium 
(Chambers and Kunin 1985), thus allowing bacteria to colonize the urinary tract 
1.2. Betaines in humans 
1.2.1. Osmolytes and cell volume regulation 
Glycine betaine is used as an osmolyte in kidney cells (8agnasco et al. 1986; Sizeland et al. 1993), 
and it is important for cell volume regulation'of kidney cells (Kwon 1998). Active accumulation 
of glycine betaine normally only occurs in the kidney, but osmo-sensitive glycine betaine 
transporter pumps can be found in many different human cell types including liver, kidney 
(Huassinger et aL 1998) and endothelial (Petronini et al. 2000) cells. Most human cells other than 
kidney cells are surrounded by interstitial fluid which in healthy humans has a constant osmolality. 
There are a number of other osmolytes that are utilized by the kidneys, including inositol and 
sorbitol (Schmolke et al. 1991). Glycine betaine is used as an osmolyte in other tissues when 
required; for example, hypernatremia (high blood Na+ levels) causes more than a 50% increase 
in the glycine betaine content of brain cells (Lien et al. 1990). 
1.2.2. Role as a methyl donor 
In animals, as well as some unicellular organisms, glycine betaine donates a methyl group to 
homocysteine in a reaction catalysed by betaine homocysteine methyl transferase (8HMT; E.C. 
2.1.1.5) forming the products N,N-dimethylglycine and methionine (figure 1.2). Regulation is 
complex in mammals, with both transcriptional and post translational regulation present as well 
as feedback inhibition by N,N-dimethylglycine (Garrow 1996). BHMT is present in the liver and 
kidney of mammals (Sunden et aL 1998), ami has been reported in other tissues sllch the eye (Rao 
et al. \998). There is no apparent correlation between BHMT activity and the level of plasma 
glycine betaine in rats, and the activity also appeared to be insensitive to tissue glycine betaine 
(£l 
(CH3hNCH2COO 
I 
CH3 
Glycine betaine 
CH2CH2SH 
.. CBS ® I 
Cystaihionme ... 411('---- H3N ~COO 
VitB6 
CL lVitB6 Homocysteine 
Cysteine 
MTIIF 
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N,N dimefuylglycine 
BHMf~ 
Methionine 
MS 
1HF 
Folate 
Figure 1.2: Metabolic pathway showing the metabolism of homocysteine. 
CBS: cystathionine • -synthase. Cl: cystathionine· -lyase. MS: methionine synthase. 
MTHF: S-methyltetrahydrofolate. MTHFR: 5,1 O-methylenetetrahydrofolate reductase. 
THF: tetrahydrofolate. Vit 8 6 : vitamin 86 (pyridoxal phosphate). 
concentration (Finkelstein et al. 1983). Proline betaine can act as a substrate for purified porcine 
BHMT (Mulligan et aL 1998), but whether this occurs in human physiology is unknown. 
1.2.3. 
1.2.3.1. 
Glycine betaine homeostasis 
Regulation in blood plasma 
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The level of glycine betaine in blood plasma is highly regulated in mammals. Plasma levels are 
regulated with variable individual set points generally between 20-70 .. moll- l in healthy humans, 
and concentrations generally remain within 20% of the individual's set point. Within an individual 
the set point appears to be constant, at least over three years (figure 1.3A), and possibly longer 
(Chambers and Lever 1996). Plasma concentrations are 23% (female) and 32% (male) lower 
(P<O.1 and P<O.OOI) in patients with renal disease, but there is no significant difference in the 
plasma glycine betaine concentration in diabetics and healthy people. 
1.2.3.2. Source of glycine betaine 
Glycine betaine can be obtained either through the diet, or it can be endogenously synthesized 
fi-om choline via the enzymes choline dehydrogenase (E.c. 1.1.99.1, an alcohol dehydrogenase) 
and betaine aldehyde dehydrogenase (E. C. 1.2.1.8) (Flower et al. 1972). Synthesis occurs in the 
100,------------, 
80 
20 • 
A 
• 
20 40 60 80 100 
Original plasma betaine 
(llmolll) 
104 .,------------, 
B 
Ii! 
10-1 l..-.;... ........... "-'-u..u.u"-'-............ "-'-........... 01..-1............w 
10-1 100 101 102 103 104 
Original urine betaine 
(mmollmol creatinine) 
Figure 1.3: Plots showing homoeostasis of glycine betaine and proline 
betaine over three years. Plot A shows the change in plasma glycine betaine 
(red circles) and proline betaine (blue squares) concentrations over three 
years. Plot B shows the change in urinary glycine betaine (red circles) and 
proline betaine (blue squares) concentrations over three years. Graph taken 
from Lever et al. (unpublished data). 
J J 
J, Backgrounu 
liver and kidney (reviewed in Zeisel 1981). Conversion of choline to glycine betaine also occurs 
in the stomach (Flower et a!. 1972), due to either bacteria, or the cells in the epithelium of the 
stomach, Approximately half of the choline consumed in the diet is converted to glycine betaine 
in the gut of hamsters (Flower et al. 1972), Some choline that is ingested is instead converted to 
trimethylamine by bacteria in the gut (de la Huerga and Popper 1952; Asato and Simenhoff 1965). 
Prior to this project, there was little data on the glycine betaine or choline content of the diet, 
other than for a small number offoods that have high levels. There is strong evidence that glycine 
betaine consumed is absorbed into the blood stream, as patients with chronic renal failure 
(McGregor 2001) and homocystinuria (reviewed in Sakura et al. 1998) given oni! glycine betaine 
supplements show a marked increase in plasma glycine betaine. 
1.2.3.3. Loss of glycine betaine 
Glycine betaine can be converted to N,N-dimethylglycine by the transfer of a methyl group to 
homocysteine as described earlier (section 1.2.2), and some glycine betaine is excreted in the urine 
(Lever et a1. 1994a). Healthy kidneys are able to efficiently reabsorb glycine betaine, with a 
fractional clearance of only 3-5% (Lever et al. 1994a). Most of the resorbance occurs in the 
proximal tubules, but it can also occur in Henle's loops in rats (Pummel' et al. 2000). The urinary 
excretion of glycine betaine has been.shown to be increased in diabetes mellitus (both type 1 and 
type 2) and renal failure (Lever et a1. 1994b; Dellow et al. 1999). 
1.2.4. Dietary betaines 
At least three betaines that are not know to be synthesised or required by humans have been 
detected in human specimens, indicating that betaines obtained in the diet are absorbed in to the 
circulatory system in humans. Trigonelline and proline have been found both plasma and urine 
(Lever et al. 1994a), and arsenobetaine has been found in urine (Fowler 1977). There is a 
correlation between the plasma concentrations of proline betaine and trigonelline and the presence 
of these compounds in the urine. These compounds are not accumulated in the kidney, unlike 
glycine betaine (Lever et al. 1994a). The concentrations of these betaines in the blood is very 
variable (figure 1.3A), and the physiological effects ofthese compounds ifunknown. A cOITelation 
between proline betaine excretion and gl ycine betaine excretion was noted by et al. (1994a), 
but no explunntion for this was given and the reason(s) is still unknown. Trigonelline has been 
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proposed as a antidiabetic substance, but no studies into this have been carried out (reviewed in 
AI-Habori and Raman 1998). Arsenobetaine is a non-toxic arsenic compound that can sometimes 
be found in urine after ingestion of seafood. Arsenobetaine has caused problems in the 
measurement of arsenic in humans, because traditional tests are unable to distinguish between 
inorganic (toxic) and organic (non-toxic) forms of arsenic (reviewed in Fowler 1977). Recently 
techniques for distinguishing the forms have been developed (Mester and Fodor 1997), allowing 
the concentrations of toxic arsenic to be accurately determined. 
1.3. Homocystei~e 
Homocysteine is a non-protein amino acid (figure 1.2) which is an intermediate in methyl transfer 
reactions and a byproduct of protein meta,bolism. Plasma homocysteine concentrations are 
homoeostatically controlled in mammals, primarily by the liver and, to a lesser extent, the kidneys 
(Finkelstein 1998). Normal levels are between 5 and 17 ,LimOn-! in plasma (Schreiner et al. 1997). 
Homocysteine can be metabolized through three different pathways in mammals (figure 1.2). Two 
of these pathways are dependent on B vitamins; the folate dependent THF pathway, and the 
vitamin B6 dependent pathway (Finkelstein 1998). The other pathway, described earlier, utilizes 
glycine betaine as a methyl donor, producing methionine and N,N-dimethylglycine. It should be 
noted that homocysteine converted to methionine is ultimately recycled via the SAM/SAH 
(S-adenosylmethionine/S-adenosylhomocysteine), whereas the vitamin B6 dependent pathway, 
which forms cysteine, alters the carbon backbone, and removes homocysteine from this metabolic 
cycle. 
In 1962, the first disease involving homocysteine metabolism (homocystinuria) was 
described (Gerritsen et al. 1962), (Carson and Neill 1962), and homocysteine was soon linked to 
atherosclerosis (McCully 1969). Classical homo cystinuria is a genetic metabolic disorder caused 
by a deficiency in one of the enzymes cystathionine p-synthase (CBS), methylenetetrahydrofolate 
reductase (MTHFR), or methionine synthase (MS) (figure 1.2). The symptoms of classical 
homocystinuria include mental retardation, skeletal abnormalities, and premature 
atherothrombotic disease (reviewed in Welch and Loscalzo (998). The levels of homocysteine in 
the blood plasma of patients presenting with classical homocystinuria range tl-om 50-500 ~lInon-1 
(Jacobsen (998). The incidence of homocystinuria is low, with the homozygous trait occurring 
only once in about 200 000 births (reviewed in Welch and Loscalzo 1998), 
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In recent years there has been a lot of interest in homocysteine as an independent 
risk factor for cardiovascular disease. Elevated homocysteine levels have also been associated 
with other disorders such as fetal abnonnalities (Ronsenquist et al. 1996) and cognitive 
impainnents (reviewed in Nygard et al. 1998). Mildly elevated homocysteine concentrations occur 
in 5-7% of the popUlation (reviewed in Welch and Loscalzo 1998), and are affected by lifesty Ie 
factors including smoking, and inactivity. Males tend to have higher homocysteine concentrations, 
and homocysteine concentrations increase with age. There is no apparent threshold for the risk 
of CVD, and it has been estimated that an increase of 5 moll- l confers a risk increase of 50% 
(Boushey et al. 1995). 
1.3.1. Folate studies 
A significant decrease in circulating homocysteine can be achieved with B-vitamin 
supplementation (Boushey et al. 1995; Rosenquist et al. 1996; Surtees et al. 1997; Healy et aL 
1998; den Heijer et al. 1998; Malinow et al. 1998 and Riddell et al. 2000: reviewed in Jacobsen 
1998 and Deutsch et al. 1998) and, at present, patients presenting with high homocysteine levels 
are generally put on a vitamin therapy, specifically receiving folate, vitamin B6 and vitamin B12. 
Although reductions in circulating levels of homocysteine are often observed, a return to nonnal 
levels is not common. 
1.3.2. Other factors effecting homocysteine 
There have been a number of recent studies which have indicated that B-group vitamins are not 
the only factors in altering plasma homocysteine levels. Nygard et al. (1995) in the Hordaland 
study found that circulating homocysteine levels were increased in smokers and heavy coffee 
drinkers, whereas they were lower in physically active people. Broekmans et al. (2000) gave 
subjects a high fruit and vegetable diet for four weeks and showed no significant change in either 
folate or vitamin BI2 levels but a lO'/"o decrease (P < 0.05) in circulating homocysteine. DeRose 
et al. (2000) showed a large reduction in circulating homocysteine levels after transferring subjeCts 
to a vegan based diet. Stickel et al. (2000) noted a large (60%) (P 0.0 I) increase in circulating 
homocysteine after giving rats high levels of alcohol, despite the provision of more than 20 times 
the basal requirement of folate and the achievement of high blood and hepatic folate levels. The 
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effect that alcohol has on homocysteine concentrations may be due to the negative effect it has 
on folate concentrations (Hillman and Steinberg 1982).All of these studies strongly suggest that 
B vitamins are not the only important factor in homocysteine metabolism, and other factors need 
to be considered. 
1.3.3. Glycine betaine and homocysteine 
Glycine betaine metabolism has not enjoyed the same level of interest that B-vitamin dependent 
pathways have. This is likely to be due to the difficulty of measuring physiological concentrations 
of glycine betaine (chapter 2). There have been a number of studies that have looked at the effects 
of glycine betaine administration on homocysteine metabolism. Wilcken et a1. (1983) gave 10 
patients with cystathionine p-synthase deficiency who were unresponsive to pyridoxine therapy 
(the standard treatment) 6 g/day of glycine betaine for between three and 13 months. All of the 
subjects experienced a marked (between 50% and 97%) decrease in circulating homocysteine, but 
only two subjects' homocysteine levels were lowered to within the normal range. Other changes 
noted in the patients included two subjects who showed a darkening of previously fair hair, and 
there were improvements in behaviour reported by school teachers or parents in six patients. 
These were not formally tested. Storch et a1. (1991) administered 3 g/day glycine betaine to 
healthy young men, and showed that there was no significant increase in glycine betaine excretion, 
although in one subject, increased excretion accounted for -17% of administered glycine betaine. 
They also observed an increase in the transmethylation rate of methionine, suggesting increased 
cycling of homocysteine and methionine. Brouwer et a1. (2000) gave healthy volunteers 6 g/day 
glycine betaine, and showed a significant decrease in plasma homocysteine after 2 weeks (10.9 
~molrl to 10.0 ~molr-I, P = 0.01), suggesting that some of the increased methionine 
transmethylation observed by Storch et a1. was due to increased flux through BHMT. 
1.3.4. Other effects of glycine betaine 
Betaine has also been given in studies unrelated to homocysteine metabolism or cell volume 
regulation, Soderl ing et a1.( 1998) reported that betaine added to toothpaste relieves symptoms 
0[' dry mouth. an oral condition that causes discomfort, increased susceptibility to oral candidosis 
and difficulty in speech and eating. It is likely that this is due to the cOLinteracting nature of glycine 
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betaine. Glycine betaine also protects the .liver (of rats) against carbon tetrachloride (CCI4 ) 
induced lipidosis (fatty infiltration of the liver) (Junnila et al. 1998) and glycine betaine has been 
hypothesized to protect the liver from the damage that can be caused during niacin therapy (used 
to treat hyperlipideamia) (McCarty 2000). The ability of glycine betaine to protect the liver is 
likely to be due to the methionine sparing effect of betaine, and its role in methyl transfer. The 
toxic effects of aluminium in rats is reversed by administration of betaine for 30 days, starting the 
day after administration of aluminium (Ramakrishna et a1. 1998) and it was suggested that betaine 
may prevent formation/stop progression of amyloid plaques and also augment choline levels, both 
of which would lessen the symptoms of Alzheimer's disease. 
There are no reports of any adverse effects associated with the supplementation of 
glycine betaine. 
1.4. Aims 
The aim of this thesis was to investigate some of the aspects of dietary betaines. Initially, a 
database of the betaine content in foods was required. This knowledge allows estimation ofthe 
intake of glycine betaine, which is important to compare to the dosages that have been given in 
some clinical trials. This knowledge also enables comparison of different diets and lifestyles, in 
particular, comparing the "normal" diet to vegetarian/vegan diets, coeliacs' (gluten free) diets, and 
the diets recommended to diabetics and heart and renal patients. Also gained is the ability to 
design a diet that is high in glycine betaine. The formation of a database also determines which 
betaines in the diet are present at levels that may be of physiological importance. Before this work 
could commence, modification of the assay to fulfil the requirements for the formation of the 
database was needed. 
The effect that glycine betaine has on human metabolism has been examined in a 
number 0 f studies, but few studies have been carried out on the effect of other betaines on human 
metabolism. This thesis aims to elucidate some of the effects of dietary betaines on human health. 
In pmiicular, the effect of trigonelline, a betaine present in coffee, is investigated in chapter 4, the 
potential of trigonelline to modulate homocysteine levels is investigated, and in chapter 5, the 
antibacterial properties of trigonelline in urine are tested. 
Chapter 2 
Assay Development 
"Result! Why, man, I have gotten a lot a/results. 
I know several thousand things that won't work." 
Thomas Edison 
2.1. Introduction 
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This chapter outlines the steps taken to optimize and test the methods used to measure the betaine 
content of a range of foods. These methods include the removal of hydrophobic compounds from 
the sample, derivatization procedure, and a range of HPLC separation systems. The resulting 
methods are summarized in section 2.5. 
The betaine assay at Canterbury Health Laboratory has evolved since 1988. During 
that time it has been optimized for the quantification of different betaines that are commonly found 
in plasma and urine samples, as well as some synthetic betaines that were candidate antimicrobial 
agents. The original assay (Lever et a1. 1992) was unable to fulfil a number of requirements of 
measuring the betaine content in the constituents of the diet: 
2.2. 
1) Earlier experience in this laboratory has shown that hydrophobic 
compounds found in some foods, especially animal homogenates, cause a 
decrease in the performance of HPLC columns, so a means of removing 
these compounds was required (section 2.2). 
2) The chromatograms have always had some reagent-derived aI1efact peaks 
which had not caused major problems and had been tolerated. However, 
some of the naturally occurring betaines run in the same area as these 
interfering compounds. For detection and quantification of these 
compounds, the interference must be reduced (section 2.3). 
3) Unique to this project was the possibility that different compounds 
co-elute with known betaines. This cannot be avoided, but it can be 
detected by using separation systems with different selectivities (section 
2.4). 
Sample preparation 
Measurement of betaines requires the derivatization in aqueolls solution (section 2.3), and then 
separation of the derivatives llsing HPLC (section 2.4). As most foods are solid. a means of 
f~nDing an aqueous extract was required. 
2.2.1. Preparing an aqueous extract 
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Analysis can only be carried out on liquid samples, so a method of obtaining an aqueous extract 
from foods was required. A general method (described in section 2.5.1.1) of obtaining an aqueous 
extract was designed in association with Crop and Food Research Ltd (Athar 2000). Alterations 
to the method were made as required, and these are described in sections 2.5.1.2 - 2.5.1.4. 
2.2.1.1. Dichloromethane extraction 
To make the final solution suitable for analysis by HPLC, hydrophobic compounds needed to be 
removed. A simple method was envisaged, involving a liquid-liquid extraction. The solvent to be 
used for this extraction needed to be hydrophobic, immiscible with water, preferably denser than 
water, and relatively non-toxic. A solvent with these properties could be added to the sample, and 
then centrifugation would result in a distinct and easily accessible upper aqueous layer. 
Dichloromethane has these properties, so was used as the extraction solvent. The extraction 
procedure is described in section 2.5.1.5, and testing is described in sections 2.2.2.1 - 2.2.2.3. 
2.2.2. Methods 
2.2.2.1. Recovery of dichloromethane extraction 
To ascertain if any betaines of interest are transferred into the dichloromethane layer, a standard 
was extracted with dichloromethane as described in section 2.5.1.5. The two layers were 
separated, and the dichloromethane layer was evaporated and any residue resuspended in H20. 
The resuspended solution, the original aqueous standard and the extracted aqueous standard were 
derivatized (2.5.2) and assayed using the Phenosphere (2.5.3.3) chromatography system. This was 
carried out in duplicate, and results are shown in section 2.2.3.1. A full description of the 
methodology can be seen in section 7.2.1. 
2.2.2.2. Meat 
To test whether the extraction procedure removes hydrophobic compounds from the aqueous 
solution, a number of meat extracts (2.5.1.1) were combined. This solution was extracted with 
dichloromethane as described in section 2.5.1.5. The two liquid layers were separated, and 
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compared to the original mixhlre using thin layer chromatography (TLC) with dichloromethane 
used as the mobile phase. The TLC plate was viewed under nonnal, blue (366 nm) and UV (254 
nm) light. 
2.2.2.3. Butter 
Butter was suspended in dichloromethane (0.5 g in 3 ml), and the resultant suspension was 
extracted as described in section 2.5.1.2. The two liquid layers were separated, and compared to 
the original mixture using thin layer chromatography (TLC) with dichloromethane used as the 
mobile phase. The TLC plate was viewed under nomml, blue (366 run) and UV (254 run) light. 
2.2.3. Results 
2.2.3.1. Recovery 
Figure 2.1 shows the resultant chromatograms from the betaine transfer experiment. The peak 
areas can be seen in table 2.1. More than 99% of the betaines were recovered in the extracted 
sample. 
2.2.3.2. Meat 
After centrifugation, three distinct layers were observed. The lowest and highest layers were 
liquid, and the middle layer was solid. This corresponds to the dichloromethane (lower) layer, a 
layer of denatured proteins and other solids, and an aqueous layer. At least two compounds could 
be seen in the dichloromethane layer (Rf=;: 1, Rf== 0.8) when the TLC plate was viewed under UV 
light, but no hydrophobic compounds were visible in either the post-extraction or the 
pre-extraction aqueous samples. 
Time (minutes) 
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32.5 35.0 
Figure 2.1: Chromatogram showing the betaine (glycine betaine and 
trigonelline) recovered after an extraction. The blue trace is a derivatization of 
the dichloromethane layer. The green trace is prior to dichloromethane 
extraction and the red trace is the aqueous layer after dichloromethane 
extraction. 
Trace 
Glycine betaine Glycine Trigonelline Trigonelline 
area (mV.sec) betaine (%) area (mV.sec) (%) 
Before Extraction 3100 100 2930 100 
After H20 layer 3070 99.1 2910 
i 99.4 
Extraction Dichloromethane 5 0.2 4.4 0.2 
layer 
Table 2.1: Efficiency of betaine extraction from a standard betaine solution. Betaine peak 
areas and percentages ofunextracted sample standard areas. 
2.2.3.3. Butter 
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The TLC of the butter extract showed the presence of some hydrophobic compounds in 
dichloromethane (pre- and post- extraction) (Rf= 0.6) whereas the only compounds seen in the 
water layer did not migrate from the initial point (Rf = 0). 
2.2.4. Discussion 
These results indicate that the extraction procedure is suitable for the removal of hydrophobic 
compounds from a wide range offoods without substantially altering the concentration ofbetaines 
that are of interest. No hydrophobic compounds were seen on the TLC plates, and virtually all of 
the betaines were recovered after extraction. 
2.3. Derivatization 
2.3.1. Background 
Betaines are intrinsically difficult to detect at physiological concentrations, and to measure them 
by HPLC a chromophore must be added to the molecule. A description of the original 
derivatization reaction can be seen in section 7.2.2. Two different chromophores have been used 
in this project. The naphthacyl functional group was favoured because of its purity and availability, 
but the 2-fluorenacyl group was used when 2-naphthacyl trifluoromethanesulfonate was in short 
supply. The chromatography of betaine derivatives with the two chromophores was essentially 
the same (data not shown). 
The chromophore was synthesized as the trifluoromethanesulfonate by the Chemistry 
Department, University of Canterbury. The chromophore is transferred from the 
trifluoromethanesulfonate to the carboxyl group of the betaine as shown in figure 2.2 (Ingalls et 
a1. 1984). This reaction only occurs in the presence of base, and the resulting betaine ester is 
unstable in the presence of base (Wittman and Ziegler 1988). 
The first part of this procedure was the drying stage. The aqueolls sample was 
diluted in derivatizatiol1 solvent and anhydrolls Na2SO.j was added in excess. The NucSO-.l 
absorbed any water, and the Na2SO.j. was then removed by centrifltgation. Because the base used 
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II 
o 
2-na~ triflate glycine betaine glycine betaine 2~ ester 
Figure 2.2: The derivatization reaction. 2-Naphthacyl trifluoromethanosulfonate 
reacts with glycine betaine in the presence of [OH-] to form glycine betaine 2-
naphthacyl ester, which can then be measured by HPLC. 
in the reaction is only slightly soluble, the water concentration had a major effect on the 
concentration of base in solution. As the rate of reaction is dependent on the amount of base 
present, it was thought to be essential to keep the amount of base constant. The water content 
was approximately 1.6% (v/v), and this comes solely from the addition of base suspension. The 
product ofthe reaction breaks down to the betaine and phenacyl alcohol in the presence of base 
(Wittman and Ziegler 1988), so basic conditions are required for formation but also cause 
degradation of the derivative. Five minutes after reactants are combined, the reaction was 
effectively stopped by centrifugation. All of the solid base was removed, making the solution no 
longer basic. The betaine derivatives were no longer formed nor degraded. 
2.3.1.1. Derivatization solvent 
The traditional solvent system used for this derivatization reaction is acetonitrile (Ingalls et al. 
1984). This has fulfilled all expectations so far, but for this project this derivatization solvent was 
not suitable. The problem with acetonitrile based systems is that acetonitrile itself is derivatized, 
and this appears on the chromatograms as an interfering peak (figure 2.3). This has been 
suspected for some time, and was finally shown by Paton et aI. (unpUblished data) using mass 
spectroscopy. Due to the inadequacies of acetonitrile, another solvent was required. The following 
requirements need to be met: 
1) 
2) 
3) 
The solvent must allow derivatization to occur. Both betaines and derivatizing 
reagent need to be soluble in the solvent. 
It is important that the solvent itself is not derivatized. 
If the solvent absorbs strongly in the UV, and the betaine derivatives are being 
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Flgure 2.3: Chromatogram showing the peak (c.13 minutes) that is created by the 
presence of acetonitrile. The solution that gave the blue trace was the same derivatized 
in acetone, and then diluted 1: 1 with acetone. The solution that gave the red trace was 
the same derivatization, but was diluted 1:1 with acetonitrile. This is peak also occurs 
if the derivatization reaction is carried out in acetonitrile. 
detected using UV absorbance, then the baseline UV absorbance would increase 
the baseline noise, and reduce the sensitivity of the assay. If the betaine 
derivatives are to be detected using fluorescence (a more sensitive detection 
method), the solvent must have low fluorescence. 
4) The solvent must be pure enough so that there are no observable artefacts on the 
HPLC traces. Purity is also important for reproducibility. 
5) The solvent must be readily available, so that the availability of the solvent is 
never an issue. 
6) AB a number of different workers will be exposed to the solvent, it is 
advantageous if the solvent is non-toxic. 
7) 
2.3.1.2. 
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A non-volatile solvent is desirable, because solvents with low boiling points may 
evaporate leading to high and inaccurate results. 
Order of reactants 
Initially, the derivatizing reagent was added prior to the base, but the reverse has been the case 
in the past. The reaction would not be predicted to occur until both base and derivatizing reagent 
are present, and there is no known reason why the order should make a difference. This was 
important to standardize the methods used by different people, and also to see if any reduction 
in steps and/or time could be achieved. 
2.3.2. Methods 
2.3.2.1. Derivatization solvent 
Properties 1, 2, 3 and 5 (section 2.3.1.1) are absolute requirements of the derivatization. A 
number of solvents that fulfilled requirements 3, 4 and 5 were tested as described in the section 
7.2.3. The HPLC traces were compared to show the relative efficiencies of derivatization (section 
2.3.3.1). 
2.3.2.2. Effect of water on derivatization 
A standard solution was derivatized in acetone with varying amounts of water and the resultant 
HPLC traces were compared. The results can be seen in section 2.3.3.2. Details can be seen in the 
section 7.2.4. 
2.3.2.3. Order of reactants 
A series of derivatizations were carried out on a standard betaine solution and a water blank. The 
order of addition of base and derivatizing reagent was altered, and were analyzed using the 
Zorbax system. The chromatograms were compared (2.3.3.3). Full experimental details can be 
seen in the section 7.2.5. 
2.3.3. 
2.3.3.1. 
Results 
Derivatization solvent 
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After centrifugation, the pellets in the samples derivatized in methanol and propan-2-01 showed 
some brown discolouration. The pellets ofthe other derivatizations were white. The peaks on the 
sample derlvatized in acetone were consistently larger than the other peaks (figure 2.4). A 
derivatization solvent consisting of 5% H20 in monoglyme generally gave the next largest peaks. 
The peaks corresponding to trimethylamine and creatinine were smaller in the acetone 
derivatization, relative to some of the other solvents tested. 
500 
'\ I' Acetone I I 
erel\ i, DMG 5% Water in monoglyme I I! 
,:" Iii GB Monoglyme Ill,l, AC ~ 10% methanol in acetonitrile 
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Figure 2.4: Overlay of chromatograms showing the effect of different derivatization 
solvents on betaine recovery. The chromatographic conditions used were the Zorbax 
conditions (section 2.5.3.1). 
AC: acetyl carnitine. Carn: carnitine. Cre: creatinine. DMG: N,N-dimethylglycine. 
GB: glycine betaine. Trig: trigonelline. 
2.3.3.2. Effect of water 
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Figure 2.5 shows six HPLC traces of a standard derivatized in acetone with 0%,5%, and 10% 
water (each in duplicate). The variation seen between the chromatograms is shown in figure 2.6. 
The variation in the betaine derivative peak areas was less than 5% between the different 
treatments. The peak area variation of trimethylamine oxide and creatinine was greater than 5%, 
but these two compounds are not betaines, and are not of interest in this study. 
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Figure 2.5: Overlay of 6 chromatograms. These were derivatized in acetone with 
0,5, and 10% H20 present (two of each). The chromatographic conditions used 
were the Zorbax conditions (section 2.5.3.1). 
AC: acetyl carnitine. Carn: carnitine. Cre: creatinine. DMG: N,N-dimethylglycine. 
GB: glycine betaine. Trig: trigonelline. 
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Figure 2.6: Graph showing the change in peak area due to water in the 
derivatization solution. The values graphed are the mean of two repeats. 
Error bars show the maximum value. 
AC: acetyl carnitine. Cam: carnitine. Cre: creatinine. DMG: NJN-
dimethylglycine. GB: glycine betaine. TMAO: trimethylamine oxide. Trig: 
trigonelline. 
2.3.3.3. Order of reactants 
No major difference between the three treatments on the betaine standard solution was seen 
(figure 2.7). The chromatograms of the water blank showed only minor differences. The main 
difference, as shown in figure 2.8, was the size of the larger contamination peak seen when the 
base was added first 
5 
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Figure 2.7: Overlay of chromatograms showing no significant 
difference when the order of addition of derivatization reactants 
is altered. The chromatographic conditions used were the 
Zorbax conditions (section 2.5.3.1). 
: acetyl carnitine. Ars: arsenobetaine. But: butyrobetaine. 
DMG: N,N-dimethylglycine. GB: glycine betaine. 
2.3.4. Discussion 
2.3.4.1. Derivatization solvent 
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The results shown in section 2.3.2. indicate that of the solvents tested, derivatization was most 
efficient in acetone. Acetone does not fulfill all ofthe criteria defined earlier (2.3. L 1), because the 
boiling point of acetone is 57°C, Ensuring that the microfuge tubes have lids on at all times except 
when required, means that acetone's volatility does not cause any problems. Monoglyme showed 
promise as a possible derivatization solvent, but its acute toxicity made acetone the more 
favourable choice. 
The peaks corresponding to trimethylamine and creatinine were substantially smaller 
in the acetone derivatization than with the other derivatization solvents. These two compounds 
10.0 
Time (minutes) 
Figure 2.8: Enlargement showing. the largest contamination peak. 
The red trace was derivatized with the base added before the 
derivatizing reagent. 
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aren't betaines, but are frequently seen in some biological samples and are derivatized 
The discolouration observed in the pellets ofthe methanol and isopropanol samples 
can be explained by a number of different possibilities. The trifiate, or an impurity present in the 
trifiate, may be insoluble in these solvents, or a side reaction forms insoluble products in these 
solvents. The later is consistent with Wittman and Ziegler (1988), who reported that the betaine 
ester is broken down in the presence of alcohols, forming an insoluble product No further 
investigations into the nature of the discolouration of the pellet were carried out. 
2.3.4.2. Effect of water 
This experiment showed that up to 10% water had a small « 5%) affect on peak area. The 
amount of water present in the derivatization mixture is approximately 3.2%, and any variation 
in the water content in the derivatization mixture would have an insignificant effect. For this 
reason, the drying step (shaking with anhydrous N~S04 for an hour) in the derivatization 
procedure was discontinued, removing a liquid transfer and making the procedure simpler and 
quicker. 
2.3.4.3. Order of reactants 
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The only difference noted was a larger contamination peak observed in the blank when the base 
was added prior to the trifluoromethanesulfonate. It should be noted that the contamination peaks 
observed in these chromatograms were all insignificant, and all of the methods gave suitable 
results. Because no significant differences were observed, the simplest method and quickest 
method was chosen. 
2.3.5. Discussion 
The resulting derivatization reaction is simpler than the original method, and the baseline is 
cleaner. The main disadvantage of the final method is that evaporation may occur, and needs to 
be minimized. The full method can be seen in section 2.5.2. 
2.4. HPLC 
2.4.1. Columns 
2.4.1.1. Zorbax 
A previous worker used this column (Zorbax 300 SCX, 250x4.6 mm) in an attempt to separate 
acetyl camitine, camitine, N,N-dimethylglycine, glycine betaine, proline betaine and trigonelline 
(ie, the betaines commonly seen in human samples). The existing HPLC system (Allwood, 
unpublished data, section 2.5.3.1) was tried with betaines of interest, and separation was excellent 
for them, so the system was used. 
The pressure slowly increased, and this system required constant cleaning of the 
column and hardware. To counter this, the system was washed regularly (after every 40 hours of 
use) with propan-2-ol and dichloromethane. This complemented the rinsing (with 10% water in 
acetonitrile) that the column received after each nll1, and kept the column pressure within 
acceptable limits. Eventually the decrease in column efficiency (peak sharpness) and asymmetrical 
peaks (figure 2.9) became too great to achieve sufficient selectivity. 
35 
30 
25 
~ 
"-" 
20 
<l> 
V> 
~ 
8.. 15 V> 
~ 
10 
5 
10 15 20 25 
Time (minutes) 
31 
2. Assay Development 
Figure 2.9: Overlay showing typical ,asymmetric peaks on the Zorbax 
column. The column was retired after this recording. Each trace is of a 
single betaine standard. 
2.4.1.2. Alumina 
The alumina system, which was optimized by other investigators in the laboratory, was not 
altered. This system takes 60 minutes per sample, so occupies the HPLC unit for long periods of 
time, and uses excessive volumes of solvent. This system is resilient, and has excellent resolution 
(system described in 2.5.3.3). 
2.4.1.3. Nucleosil 
A Phenomenex Nucleosil5 ,urn SA 100A 250x4.0 mm column was obtained. A buffer consisting 
o ftetramethyl ammonium hydroxide and glycolic acid in a ratio of 1:2 in a mixture of acetonitrile 
and water was suggested as a starting point. 
2.4.1.4. Phenosphere 
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A Phenomenex Phenosphere 5 /lm SCX 80A 250x4.8mm column was obtained. This column has 
some similarities to the Zorbax column, and given the success of the Zorbax system, it was used 
as base for development of the Phenosphere system. 
2.4.2. Methods 
2.4.2.1. Nucleosil 
The mobile phase initially tested was the same as the Zorbax system (table 2.2). No peaks were 
seen, so the buffer content was lowered (to 1II0th and then 1I20th of the initial concentration by 
diluting the mobile phase) in an effort to increase retention times. 
2.4.2.2. Phenosphere 
A standard was derivatized and separated using the same mobile phase as the Zorbax system 
(table 2.2) but with half the buffer concentration. The retention times were too long (figure 2.10). 
Increasing the buffer concentrations increases the competition for the stationary phase (ie, the 
column), which shortens the run time (Johnson and Stevenson 1978). The buffer 
System Column Guard column Solvent Buffer Run Time 
Phenosphere Phenosphere 5 jJ.m SecurityGuard™ 10% 7 mmoW1 TMAH 35 min 
SCX 80A 250x4.8 SCX 4x3.0 mm H20 in and 14 mmoW1 
mm serial #351541 cartridge ACN glycolic acid 
Zorbax Zorbax 300 SCX, SecurityGuard™ 5%HP 7 mmoll"1 TMAH 35 min 
250x4.6 mm, P.N SCX 4x3.0 mm in ACN and 14 mmoW1 
no. 880962.704 cartridge glycolic acid 
Ahunina Merck 5 jJ.m Merck 5 jJ.m 9% H2O 10 mmoW1 60 min 
alumina 250x4 mm UChroCART 4-4 in ACN succinic acid, 
cartridge aluspher AI 100 and 3.7 mmoU-1 
TEA 
Table 2.1: Conditions of the different HPLC systems used. All chromatograms were 
recorded and analyzed using Delta Chromatographic Software (Version 5.0, Dataworx 
pty Ltd). 
ACN: acetonitrile. TMAH: tetramethyl ammonium hydroxide. TEA: triethyl ammonium 
* 
* 
o 
o 5 10 
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7.0 mM TMAfJ. 14 mM glycolate,S % water in acel:oni'lri 
7.0 111M TMAH, 14 111M glycolate, 10 % water in 
3.5 mM TMAH, 7mM glycolate, 5 % water in ",,<:;IIUll.lUll<:; 
15 20 25 30 35 
Time (minutes) 
40 45 50 
Figure 2.10: Overlay of chromatograms of standard betaine mix (100 /lmoU-1 
each of acetyl carnitine, carnitine, glycine betaine, N,N~dimethylglycine and 
trigonelline) using different moblie phases. The .. represent peaks 
corresponding to betaines. 
concentration was increased, using the same mobile phase as the Zorbax system. The run time of 
this was longer than ideal, and the separation, especially of earlier betaines, was not good. 
Increasing the buffer further would make the early peaks even earlier and also increases the 
likelihood of salt precipitation, so instead the water content of the mobile phase was increased. 
2.4.3. Results 
HPLC columns are designed to work at an optimal flow rate. The columns used in this project 
have all been designed to work bestat approximately I mlImin. Resolution is sometimes enhanced 
by lowering the flow rate. Chromatograms recorded at 0.5 mllmin and 1 mllmin were compared, 
and no difference in resolution was seen (data not shown). 
2.4.3.1. Nucleosil 
34 
2. Assay Development 
No peaks were seen after 60 minutes when the buffer used was the same as the Zorbax buffer. 
When the buffer was decreased to 11 10th and then 1I20th of the original concentration, peaks 
were still not seen. No more attempts to separate betaine derivatives with this column were made. 
2.4.3.2. Phenosphere 
Figure 2.10 shows a series of chromatograms of the same sample separated using different mobile 
phases. The first important peak (N,N-dimethylglycine) on the blue trace had a retention time of 
about 22 minutes, and the third peak (glycine betaine) to come out had a retention time of about 
53 minutes. The remaining two betaines eluted at a later time, but the run time required for this 
mobile phase was deemed to be excessive and recording was stopped after 55 minutes. The buffer 
concentration was increased for the next chromatogram (red trace), giving retention times for the 
five betaine derivatives ranging between 15 and 45 minutes. A chromatogram of a different range 
of derivatized betaines showed that separation was achieved, but could be improved, especially 
for betaine derivatives with early retention times (data not shown). A run time of 45 minutes 
would be usable, but a shorter run time would be preferred. The water content of the mobile 
phase as increased for the green trace. This altered the selectivity, so that the betaines of interest 
had retention times between 15 and 30 minutes. 
2.5. Conclusion 
The following sections describe extraction, derivatization and HPLC methods that are suitable for 
analyzing a range of food samples for betaine content. These methods were used for all analyses 
described in chapter 3. 
2.5.1. Extraction procedure 
2.5.1.1. Solid foods 
Foods were uncooked, and all edible parts \vere put into a .standard kitchen food processor 
(MOlllillcx MlIltimoulillette, Model T71). The food was processed so that no pieces were greater 
than 5111111 across. From this, a portion (0.5 - 1 g) was transferred to a pre-weighed test lube. This 
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was homogenized for at least one minute using an Ultra Turrax homogenizer. If a homogeneous 
paste could not be achieved, water (recorded volume) was added. This mixture was then shaken 
for a minimum of five minutes, and centrifuged (5 min at 4000 rpm). This yielded a liquid layer, 
which was removed and extracted with dichloromethane as described in section 2.5.1.5. 
2.5.1.2. Fatty foods 
Some foods were unsuitable for the method described in section (2.5.1.1), due to their 
hydrophobicity (ie, butter and oils). Instead of the food being homogenized in aqueous solvent, 
the food was suspended in dichloromethane. This suspension was then extracted with an equal 
volume of water. After shaking for five minutes, the two solvents were separated by 
centrifugation, and the top (aqueous) layer was transferred and stored for assay. 
2.5.1.3. Liquid foods 
Liquid foods were shaken before analvsis with equal volumes of dichloromethane as described in 
- . 
section 2.5.1.5. After centrifugation, the top aqueous layer was removed and stored until analysis. 
2.5.1.4. Other foods 
All foods were able to be processed using the above methods except for cheese. Knowing that 
cheese has a relatively low melting point, I decided to homogenize cheese in hot water. One part 
cheese and two parts water were combined in a test tube, and heated to c.70oe in a water bath, 
fonning a homogeneous solution. This was allowed to cool, and then a dichloromethane 
extraction was carried out as described below. No thennal degradation ofbetaines occurs below 
temperatures of 2000e (Payne and de Zwart, unpublished data). 
2.5.1 Dichloromethane extraction 
To remove any hydrophobic compounds present in a sample, a dichloromethane extraction was 
carried out. An aliquot of the aqueous extract was transferred to a microfuge tube, and an equal 
amount (v/v) of dichloromethane was added. This was shaken for five minutes before 
centrifugation. After centrifugation, the top (aqueous) layer was transferred to a fresh microfuge 
tube and stored for analysis. 
2.5.2. Derivatization procedure 
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A 5 ,ul aliquot of sample was added to 250,u1 of acetone. This was vortexed immediately to break 
up any denatured proteins. Derivatizing reagent (50 I.·d, 100 mmoU- 1 naphthacyl 
trifluoromethanesulfonate in acetone) was added, followed by addition the of 5 ,ul of Mg(OH)2 
solution(O.l glml MgO suspended in distilled water) and the solution was shaken for five minutes. 
This mixture was then centrifuged (5 min, 11000 rpm) and the supernatant was transferred to an 
HPLC vial for analysis. Vials were capped immediately to stop concentration by evaporation. 
2.5.3. HPLC 
Three different chromatographic conditions were used in this thesis, as described below. 
2.5.3.1. Zorbax 
The conditions ofthis system are described in table 2.2. A chromatogram showing the separation 
of a range of naturally occurring betaines can be seen in figure 2.11 (A). 
2.5.3.2. Alumina 
The conditions of this system are described in table 2.2. The alumina system that was optimized 
by Dellow (Dellow et a1. 1999) to separate glycine betaine from acetyl carnitine, carnitine, 
trigonelline and proline betaine. A chromatogram showing the separation of a range of naturally 
occurring betaines can be seen in figure 2.11 (B). 
2.5.3.3. Phenosphere 
The conditions of this system are described in table 2.2. A chromatogram showing the separation 
of a range of naturally occurring betaines can be seen in figure 2.11 (C). 
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Figure 2.11: Overlays showing the separation achieved by the different 
chromatographic systems. Each colour represents a different standard. A: Zorbax 
system. B: Alumina system. C: Phenosphere system. 
AC: acetyl carnitine. Ars: arsenobetaine. Bet: betonicine. But: butryrobetaine. 
Carn: carnitine. Cre: creatinine. DMSP: dimethylsulfonopropionate. DMG: N,N-
dimethylglycine. Erg: ergothionine. GB: glycine betaine. PB: proline betaine. Pro: 
propionobetaine. Trig: trigonelline. 
Chapter 3 
Dietary Betaines 
"Tell me what you eat and J will tell you what you are." 
Anthelme Brillat-Savarin 
3.1. Introduction 
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A number ofbetaines are known to be present in the diet, and investigations suggest that they may 
have important physiological effects, Glycine betaine has been used as a therapeutic agent to treat 
homocystinuria and regulate mild hyperhomocysteinemia, and has been used to treat other 
disorders (see sections 1.3, 1.4), Some studies have documented no effect, whereas others have 
shown positive effects. No studies documenting negative effects on the health of patients have 
been published. For more information on this topic, see section 1. The enzyme betaine-
homocysteine methyl transferase (BHMT) metabolizes glycine betaine in mammals, and studies 
on purified porcine BHMT have revealed that proline betaine, which is present in citrus and 
legumes, is a substrate (albeit a poor one) (Mulligan et al. 1998), but proline betaine may act as 
a competitive inhibitor under in vivo conditions. DMSP (dimethylsulfonopropionate) is a betaine 
that is present in the sea and is accumulated by filter-feeders (Ishiba 1995). Purified BHMT 
studies show that DMSP is approximately seven times more effective as a substrate than the 
natural substrate, glycine betaine (reviewed in Garrow 1996). These two examples show that 
dietary betaines may interact with BHMT, and thus have an effect on plasma homocysteine 
concentrations (figure 3.1), which may, in tum, affect the risk of cardiovascular disease (see 
section 1.3). There is an association between high coffee consumption (>9 cups/day) and plasma 
homocysteine concentrations (Nygard 1997), but no mechanism for this has been published. One 
possibility is that a betaine in coffee interacts with BHMT, resulting in higher homocysteine 
concentrations. Trigonelline is a betaine that is found in coffee (Wu 1997; Stennert 1994; Martin 
1997) and it may be responsible for the association between coffee and homocysteine 
concentrations. This topic is discussed and tested in chapter 5, Trigonelline redq.ces the growth 
rate of E. coli (in vivo) in some conditions, which may make it antibacterial in urine. The testing 
of this fonns the basis of section 5. 
The betaines trigonelline, arsenobetaine and proline betaine can be detected in human 
urine (Chambers and Kunin 1985; Lever et al. 1994a), and their presence is dependent on the diet 
of the individual. This shows that dietary betaines are absorbed in to the blood stream, so may 
interact with BHMT in vitro. 
Since dietary betaines may be of medical importance, it is important to assess the 
betaine content consumed in the typical diet. At the start of this project, no data was available to 
estimate the levels ofbetaincs in the diet, and (his chapter outlines the steps taken in the formation 
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Figure 3.1: The potential interaction of dietary betaines with the 
reaction catalysed by BHMT. 
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of a database of betaine content of foods commonly found in the average New Zealand diet. These 
are summarized in tables 3.3 - 3.5. Foods that have high betaine contents were also analysed for 
variation (table 3.6, figure 3.2). The data were used to approximate the average daily intake, and 
a diet high in various betaines has been designed. 
3.1.1. Strategy 
The aim of any food survey is to discover the content in a range of different foods. Ideally, this 
would yield the average content and variation between samples, but to do this with absolute 
certainty, the content of each sample needs to be measured. As this was not possible, a sampling 
strategy was required. 
The initial strategy was to survey a wide range of common foods and food groups 
to establish which foods contain significant amounts of known betaines. This survey would also 
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establish if any unlrnown betaines present in the diet. A detailed analysis followed, to establish the 
variation of betaines in foods with high betaine levels. 
3.2. Methods 
3.2.1. Assay 
Aqueous extracts were prepared as described in section 2.5. L The prepared samples were then 
derivatized as described in section 2.5.2. The derivatized samples were separated and betaines 
quantified using the Zorbax, alumina and Phenosphere chromatographic systems as described in 
section 2.5.3. 
Fruit/vegetables Dairy Meat/fish Miscellaneous 
Alfalfa sprouts Butter Beef Canola oil 
Bean Cottage Cheese Chicken Chocolate 
Beetroot Cream Clams Coffee 
Cabbage Cream Cheese Cod Egg 
Carrot Milk Lamb Flour 
Celery Sour Cream Monkfish Honey 
Chick peas Yoghurt Mussel Milo 
Corn Pork Olive oil 
Courgette Olivio 
Cranberry Pasta 
Cucumber Peanuts 
Feijoa Rice 
Garlic Rolled oats 
Grape . Sugar 
Grapefruit Tea 
Lemon 
Lentils 
Mango 
Nectarine 
Orange 
Passionfruit 
Pea 
Pear 
Pumpkin 
Silverbeet 
Snow pea shoots 
Spinach 
Swede 
I 
Tamarillo 
Tomato 
Table 3.1: Foods that chromatograms from two systems gave consistent results. 
Fruit/vegetables 
Apple 
Avocado 
Banana 
Broccoli 
Brussel Sprouts 
Cauliflower 
Kiwifruit 
Kumara 
Leak 
Lettuce 
Mushroom 
Onion 
Parsnip 
Pepper 
Plum 
Potato 
Yam 
Dairy Meat/fish 
Cheese Groper 
Gumard 
Perch 
Salmon 
Terakihi 
Tuna 
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Miscellaneous 
Marmite 
Wine (red) 
Soy sauce 
Vegemite 
Table 3.2: Foods which chromatograms from two systems gave differing results. 
3.2.2. Foods to be assayed 
A list of foods was assembled in conjunction with Crop and Food Research Ltd., where the New 
Zealand Food Composition Database is housed. The list of foods surveyed can be seen in tables 
3.1 and 3.2. 
3.2.3. Food Sampling 
The initial aim was to quantify the betaine levels in all food types, and then select foods that have 
significant levels and study these further to obtain data on the natural variation. A sampling 
procedure (below) was drawn up in conjunction with Crop and Food in Palmerston North. 
Wherever possible, at least two different sources of each type of food were samp led. 
In the cases where only one brand was available, two items from the same source were sampled. 
In the case of dried foods (eg, flour, sugar, pasta, etc.), approximately a cup from different 
sources was sampled. In the case of fruits, at least two individual pieces from different sources 
were sampled. Sampling of only two individuals was considered appropriate for large items (eg, 
potato, pumpkin), but inappropriate for small fruits (eg, grapes) because of the representation a 
small volume gives. For these, two cups (or equivalent) from different sources were sampled. For 
meats. il can be assumed that meat from one source may come from the same animal, so meats 
were obtained from different sources, di ftercnt butchers or supennurkets. 
3.2.4. Analysis of chromatograms 
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Each sample was analyzed using at least two chromatographic systems (section 2.5.3). A series 
of standards containing glycine betaine, trigonelline, proline betaine and arsenobetaine were 
included in each HPLC run. If the results from the two chromatographic systems were consistent 
with each other (within 15 %) then values obtained from the different systems were accepted and 
the mean concentration was reported. If the two chromatographic systems gave inconsistent 
results, the analysis was repeated using the initial two systems and a third set of conditions. 
After repeated measurements, the values from the chromatographic system giving 
the lowest concentration was used. Two different compounds may co-elute on some 
chromatographic systems, giving the impression of a higher concentration than is present. If this 
occurs, it is cornmon to see a distorted peak, but this is not always the case. Using three different 
chromatographic systems allowed this to be accurately detected. The foods listed in table 3.2 had 
differing values ofbetaines on different chromatographic systems. Each of these are discussed in 
the section 7.3.1. 
The UV detector required some maintenance during the food analyses. During the 
month that it was unavailable, a lower sensitivity UV detector was used. Using this detector, the 
assay had a detection limit of approximately 25 ,umolt
'
, whereas the usual detector gave the assay 
a detection limit of approximately 1 ,umoll" I , This detector was able to detect samples with high 
levels of betaines, but was unable to detect the lower levels found in many foods. The 
concentration of betaine in food that the limit of sensitivity corresponds to is dependent on the 
dilutions made, but generally ifless than I ,umoll- I was detected, then less than 1 ,ug/g was present 
in the food. If no betaines were detected, the concentration of betaines in that food has been 
reported as less than 1 ,ug/g. Any sample which has less than 10 ,ug/g betaine present has been 
reported as either than 10 ,ug/g or less than 5,ug/g. 
3.2.5. Calculations 
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The following equation was used to calculate the betaine content of food: 
X - CXP VxRMM 
-AX M 
Equation 3.1: Equation used to calculate betaine concentration that has 
been reported. X: Reported betaine content in food (,ug/g). C: HPLC 
standard concentration (,umoll-1). P: Sample peak area (mV.sec). A: 
Standard peak area (mV.sec). V: Volume of water added (I). RMM: Relative 
Molecular Mass (gmol'1). M: Mass of food sampled (g). 
To obtain a value for the concentration of betaine in food, a number of assumptions have been 
made. The effect of these assumptions is the value reported will be lower than the actual betaine 
content. It has been assumed that all of the water present in the homogenated sample orginates 
from the addition of water. This assumption can be justified by the assumption that any betaine 
present will be distributed evenly throughout the sample; ie, it will be present in the pellet as well 
as in the supernatant. 
For liquid foods, 1 ml was sampled, and the following equation was used: 
X= CXP xRMM 
A 
Equation 3.2: Equation used to calculate betaine concentration that has 
been reported. X: Reported betaine content in food (,ug/ml). C: HPLC 
standard concentration (,umoW1). P: Sample peak area (mV.sec). A: 
Standard peak area (mV.sec). RIVIIVI: Relative Molecular Mass (gmol-1). 
3.2.6. Variation Studies 
Foods that were identified as being high (greater than 200 /-lg/g) in betaines (listed in table 3.2) 
were further analysed. The same procedures as described above (3.2.1 - 3.2.6) were used. A 
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nwnber of samples (2 < n < 15) from different sources were assayed using the chromatographic 
system that gave the cleanest chromatography during the initial food survey. 
3.3. Results 
3.3.1. Betaine levels in food 
Table 3.2. shows the list offoods that gave consistent results between different chromatographic 
systems. Table 3.3 shows the remainder of the foods that gave inconsistent results between the 
different systems. The values reported for the foods in table 3.3 are discussed in the section 7.3 .1. 
The betaine content in foods is summarized in tables 3.4 - 3.6. 
Proline betaine Glycine betaine Trigonelline 
Beef <1 58 <1 
Chicken . <1 200 <5 
Clams 15 2500 <10 
Cod <5 25 <1 
Groper <1 12 <1 
Gumard <1 <10 <1 
Lamb <1 72 <1 
Monkfish 40 ··--500 10 
Mussel 26 1630 83 
Perch <1 26 <1 
Pork <1 41 <1 
r-~Imon <1 19 <1 
Terakihi <1 <5 <1 
... 
Tuna <1 <10 <1 
Table 3.3: Betaine concentrations in meats and seafood. All values are in /-lg/g. 
The foods that are in bold are those which have a high content of a specific 
betaine, and variation studies on these foods were carried out. Values that are 
displayed in blue are discussed in the section 7.3.1. 
Alfalfa sprouts 
Apple 
Avocado 
----~ ... ---. 
Banana 
_ Bean 
Beetroot 
... __ .. 
Broccoli 
Brussel Sprouts 
Cabbage 
Carrot 
Cauliflower 
i Celery 
Chickpeas 
Com 
i Cougette 
Cranberry 
Cucumber 
~~~ F91joa~---··· 
f----..... Garlic 
Grape 
Grapefruit 1------... --... 
Kiwifruit 
KlJmara 
Leak 
Lemon 
lentils 
Lettuce 
Mango 
Mushroom 
i Nectarine 
Onion 
Orange 
i Parsnip 
I~ pa~:frUit 
i Pear 
~ __ Pepper ••.... ~ .. -
• Plum 
i Potato 
Pumpkin 
Silverbeet 
I Snow pea shoots 
I Spinach 
Swede 
Tamarillo 
Tomato 
Yam 
Proline betaine Glycine betaine 
240 35 
<1 <5 
<1 <10 
<1 <5 
<1 30 
<5 750 
... --~ ... 
<1 <10 
34 <5 
<1 <1 
<1 <1 
<1 <10 
<1 <1 
<1 <1 
<1 <5 
<1 <1 
<1 <1 
<1 <1 
<1 <1 
<1 <10 
<1 <1 
190 <1 
<1 <5 
<5 110 
<1 <1 
120 <1 
<1 <10 
<1 <10 
<1 <1 
15 <10 
<1 <1 
<5 <5 
510 <1 
<5 <5 
<1 <1 
<1 <5 
<5 <10 
<1 <10 
<1 <5 
<1 <10 
<1 <1 
50 910 
<1 <10 
<1 740 
<5 <5 
<1 <1 
<1 <1 
<1 <5 
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Trigonelline • I 
181 
<5 
<1 
23 
58 
<5 
<J 
31 
<1 
<1 
<1 
<1 
350 
<5 
15 
<1 
<5 
<1 
<10 
<1 
<1 
<1 
<1 
<1 
<1 
250 
<5 
<1 
<5 
<1 
<10 
18 
<1 
<1 
280 
<1 
<1 
<1 
<1 
30 
<5 
160 
100 
... _---
<1 
<1 
<1 I 
<10 
Table 3.4: Betaine concentrations in fruits and vegetables. All values are in I1g/g. 
The foods that are in bold are those which have a high content of a specific 
betaine, and variation stUdies on these foods were carried out. Values that are 
displayed in blue are discussed in the section 7.3.1. 
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I 
! 
Proline betaine Glycine betaine Trigonelline 
Butter <1 <1 <1 
Canola oil <1 <1 <1 
Cheese <1 <1 <10 
Chocolate <1 <5 <5 
~. Coffee <1 <1 2200 
• Cottage Cheese <1 <5 <1 
----.-~~ ---.---~~-----. 
Cream <1 <5 <1 
Cream Cheese <1 <10 <1 
i I::gg <1 <10 <1 
Flour <1 730 <1 
I Honey <1 <1 <1 
Marmite <1 <10 <1 
Milk <1 <10 <1 
Milo <1 34 <1 
Olive oil <1 <1 <1 
Olivio <1 <5 <1 
Pasta <1 820 <1 
Peanuts <1 <5 <1 
RedWine <1 <5 14 
Rice <1 <1 <1 
i Rolled oats <1 130 
... 2~-
Sour Cream <1 <5 <1 
~Soysauce <5 <1 <1 
Sugar <1 <1 <1 
Tea <10 24 16 
Vegemite <1 <5 <1 
Yoghurt .. <1 <5 <1 
Table 3.S: Betaine concentrations in miscellaneous foods. All values are in f.tg/g 
for solid foods and f.tg/ml for liquids. The foods that are in bold are those which 
have a high content of a specific betaine, and variation studies on these foods were 
carried out. Values that are displayed in blue are discussed in the section 7.3.1. 
Glycine betaine Trigonelline Proline Betaine 
Shellfish Sprouts Citrus fruit 
Pasta Pea Sprouts 
Flour ! Oats 
Oats 
Sprouts 
Beetroot i 
Table 3.6: Foods that have been analysed for variation. 
i 
I 
. 
3.3.2. Variation studies 
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The foods that were analysed for variation of betaine content are listed in table 3.7. The 
variation can found can be seen in figure 3.2. 
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Figure 3.2: Graphs showing the variation of different betaines (glycine betaine, 
trigonelline, proline betaine and dimethylsulfonopropionate (DMSP) in food. Between 
2 and 15 samples of each food type were analyzed. Boxes represent the interquartile 
range, error bars represent the 95th percentile. 
3.4. Summary 
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Glycine betaine can be found in animal products, especially shellfish, and in some plants, 
specifically members of the beet family (eg. beetroot, spinach) and grains. Trigonelline is found 
in legumes, and in high levels in coffee. Proline betaine can be found in legumes and citrus fruit. 
DMSP was only detected in shellfish with levels ranged from 20 to 200 j..1g/g (figure 3.2). It 
should be noted that foods in which DMSP was detected also had high (c. 10 fold higher) levels 
of glycine betaine. 
A small amount of arsenobetaine was detected in the gumard extract in all 
chromatographic systems, corresponding to between 2 and 10 j..1gl g. This has been reported as less 
than 10 j..1g/g. A similarly small level was detected in perch (5.6 and 10.1 j..1moll-1, 2.4 and 4.3 
j..1g/g) , No other food showed detectable levels of arsenobetaine. 
3.5. Conclusion 
Quantitatively, the only betaines that are present in the diet at a reasonable level are acetyl 
camitine, camitine, glycine betaine, proline betaine and trigonelline. Acetyl camitine and camitine 
have not been included in this study, because exhaustive data on the content of these betaines in 
the diet and the physiological effects exists (reviewed in Rebouche 1992). The levels of the 
remaining betaines in the diet is almost solely attributable to a small number of foods. 
Investigations into the losses ofbetaines during cooking showed that betaines are heat stable up 
to 220°C No significant losses ofbetaines were seen during baking, microwaving or frying, and 
small losses were seen during steaming. Large losses (60-80%) occurred during boiling, but this 
was recoverable from the water (Payne and de Zwart, unpublished data). 
These data and data from the New Zealand Total Diet Survey by ESR (Cressey 
200 I) in Christchurch were used to estimate the levels of glycine betaine in a normal diet at 
150-200 mg/day. According to published data. the level of glycine betaine intake could potentially 
be increased by up to 500 mg/day due to the conversion of choline to glycine betaine by gut 
bacteria and the cells in the gut wall (Zcisel 1994). The average daily intake of trigonelline and 
proline betaine is 20 and 15 mg/day respectively. It should be reiterated that these values will be 
variable because of the variation of diets and the variation present in foods. 
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A diet was designed specifically to maximise the amount of glycine betaine and 
proline betaine ingested (Price 2001). This gave a daily intake of 620 mg glycine betaine and 140 
mg proline betaine. These levels are assumed to be the approximate the limit of intake of these 
betaines through the diet without specific supplementation. The diet that gave these figures is in 
the appendix 7.3.2. 
3.5.1. Comparisons with reported data 
Trigonelline levels in green coffee has been measured numerous times, and the levels of the two 
most common varieties are in the range of 6000 to 13000 f.,J-g/g (Coffea arabica) and 3000 to 
11000 f.,J-g/g (Coffea robusta) (reviewed by Stennert, 1994). Stennert and Maier (1994) examined 
a range of roasted coffee beans, and reported an average of 6200 f.,J-g (range 4300 to 7100 f.,J-g) 
trigonelline per gram of dry matter. Other ~eports consistently give the trigonelline level at 
approximately 1 % (10000 f.,J-g/g) (Wu, 1997). The value reported in this study (2000 f.,J-g/g) is 
lower than these values. The value here does not take into account the water content of roasted 
coffee beans, which may account for the lower value. The extraction method used for this study 
was infusion, using a standard household coffee plunger. This may not extract all of the 
trigonelline in coffee beans, but it more closely resembles what is consumed. 
A study of 15 different types of wine was reported by Mar and Zeisel (1999), 
showing that the glycine betaine content ranged from 2.5 f.,J-g/ml to 24.7 f.,J-g/mL The average 
content was 11 f.,J-g/ml (red) and 10 f.,J-g/rnl (white). The present investigation tested only one wine, 
and the glycine betaine content found was within the range reported. The glycine betaine content 
is low compared to other dietary components, so is assumed to be insignificant. 
3.6. Discussion 
The main source of glycine betaine in the New Zealand diet is from flour products (eg, bread, 
pasta), but shellfish are a very good source (Cressey 200 I). Shellfish isn't consumed as much or 
as often, which means that the glycine betaine intake can be substantially increased by their 
consumption. A similar case exists with proline betaine. Most proline bctaine in the diet originates 
from citrus fruit, and in most cases it would be simple to increase the consumption of citrus fruit, 
thus increasing proline betaine intake. 
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The variation in betaine content is high, often over 50%. lfthe biological functions 
of betaines is taken into account, this finding is not surprising. As an osmoprotectant, glycine 
betaine levels would be expected to be dependent on the stress levels of the organism. For 
example, an oat grown in a drought would be expected to have a higher level of glycine betaine 
then one grown in a well irrigated field. DMSP is also an osmoprotectant, and the levels present 
may depend on the processing (Payne and de Zwart, unpublished data). Also, since trigonelline 
acts as a signal for rhizobium, the levels would be expected to alter through the life of the legume. 
Chapter 4 
Coffee and Homocysteine 
"Nair comme Ie diable, chaud comme I 'enfer, pur comme un ange, doux comme I 'amour." 
("Blackas the devil,hot as hell, pure as an angel, sweet as love.") 
Charles Maurice de Talleyrand-Perigold 
describing his concept of a good cup of coffee 
4.1. Introduction 
53 
4. Coffee and Homocysteine 
Coffee is one of the most popular drinks in the world, with over 400 billion cups of coffee 
consumed annually. Throughout its history, coffee has been the subject of controversy. Pope 
Clemente VII was urged by members of the Catholic Church to forbid the consumption of the 
"devil's beverage," and instead the Pope blessed it (Pettigrew, 1998; Kolpas, 1979). Khair Beg, 
the corrupt governor of Mecca, tried to ban coffee in 1511, for fear that its influence might foster 
opposition to his rule. On hearing of this, the Sultan sent word that coffee is sacred and revoked 
the decision, initiating a chain of events leading to Khair Beg's execution (Kolpas, 1979). In 1675, 
King Charles II tried to suppress coffeehouses, supposedly because men were neglecting their 
families to discuss business and politics over coffee. Public outcry caused him to revoke his 
proclamation (Trager, 1995). Another public outcry in 1775 also caused Frederick the Great to 
change his mind after he tried to block coffee imports (Kolpas, 1979). Now, however, the 
controversy surrounding coffee is whether it is good for you. Many would claim that their lives 
would be much emptier with out their morning cuppa, but there is evidence that coffee 
consumption has adverse health effects. 
Some studies have shown an association between coffee consumption and the risk 
of ischemic heart disease (Wilhelmsen et a1. 2001), but other studies do not (Kleemola et al. 2000; 
Woodward and Tunstall-Pedoe 1999). There is a significantly higher plasma homocysteine 
concentration (18.4% in males and 28.9% in females, P<O.OO 1) associated with high coffee 
consumption (9 cups/day) (Nygard et al. 1997). This remains after adjusting for other factors 
Imown to affect plasma homocysteine concentration (age, smoking, diet, activity level), and 
corresponds to an increase in homocysteine concentrations of 1.9 (male) and 2.3 (female) ~moltl. 
No attempt to explain this difference in homocysteine levels was made. Similar observations have 
been reported by Urgert et aL (1996) and Olthof et aL (2001). It has been estimated that 5 ~moll"l 
increment in plasma homocysteine corresponds to a 50 % increased risk of arteriosclerotic 
vascular disease (Boushey et al. 1995). 
Trigonelline is found in co ffee at concentrations of up to 1 (Yo by dry weight (Stennel1 
and Maier 1994), and this is the main source of trigonelline in most diets (chapter 3). Trigonelline 
is stmcturally related to gJycine betaine (figure 4.1), and it was hypothesized that the trigonelline 
present in coffee interacts with betaine-homocysteine methyl transferase (BHMT) causing an 
increase in the level of homocysteine in the blood plasma. This hypothesis was tested by 
Figure 4.1: Structures of trigonelline (left) and glycine betaine 
(right). 
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challenging subjects with a coffee load. Over the course of a day, plasma was collected, and 
glycine betaine and homocysteine were measured. 
4.2. Methods 
4.2.1. Ethical Approval 
As any study involving humans requires ethical approval, an application for approval to perform 
fue study was made. The initial proto co 1 was designed with assistance from a member of fue local 
ethics committee. An information sheet, giving the reasons and details ofthe study and a consent 
form were created and submitted to the Canterbury Ethics Committee (protocol, information 
sheet and consent form). Afterminorrecommended changes were made, permission to carry out 
the study was granted. The consent form and information sheet are in section 7.4. 
4.2.2. Volunteers 
Eight males and two females aged 20-30, non-diabetic, non-smokers and in good health, were 
recruited. Each subject was asked to abstain from coffee for the three days plior to the triaL No 
other dietary restrictions were made. One volunteer was withdrawn from the trial due to 
difficulties with insertion of a functional indwelling catheter for blood sampling. 
4.2.3. Coffee 
55 
4. Coffee and Homocysteine 
Coffee was produced by brewing 37 g of coarse ground coffee (New York Style roast, Garden 
City Coffee, Christchurch, New Zealand) in a French Press (plunger) with 1000 ml near-boiling 
water for 4 minutes. 
4.2.4. Trial 
Participants were given a total of 1000 ml of coffee to be consumed between 9:00 am and 10:00 
am. Throughout the trial period, participants had free access to water. Lunch and refreshments 
(previously tested to confinn it was low in betaines) were supplied. A summary of the trial can 
be seen in figure 4.2. 
4.2.5. Sample collection 
Baseline blood samples were drawn at 8:20 am, 8:40 am and 9:00 am on the day of the trial. 
Blood samples were drawn hourly for the next eight hours. Blood samples were collected in 
heparinized tubes, and put on ice immediately. Samples were separated (centrifuged for 10 min 
at 6000 rpm) within five minutes of collection, and the plasma was frozen until analysis. This 
blood collection method is required for accurate homocysteine measurements (IMx, 2000). 
8 9 10 11 12 13 
Time (24 hour clock) 
14 15 16 
I 
17 
Figure 4.2: Timing of the trial. Blue arrows represent points at which blood samples 
were drawn. The red box represents the time when the coffee was consumed. At least 
one urine was collected prior to coffee ingestion for each participant, and all urine 
produced during the day (no set times) was collected. 
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The participants were asked to empty their bladders before the coffee was 
consumed. Subsequent urine produced during the day, as well as the baseline urine, were 
collected. All urine volumes were measured, and an aliquot was frozen for analysis. 
4.2.6. Biochemical Analysis 
Plasma was analysed for N,N~dimethylglycine, glycine betaine, trigonelline and homocysteine. 
Urines were analysed for creatinine, glycine betaine, trigonelline, urea and osmolality. 
N,N~Dimethylglycine, glycine betaine and trigonelline concentrations were assayed using the 
alumina as described in section 2.5. Creatinine concentrations were analysed using the Jaffe 
Method (Murray, 1984), and osmolalities were measured by freezing point depression. 
Homocysteine concentrations were assayed by Canterbury Health Laboratories (IMx, 2000). Urea 
concentrations were measured by Canterbury Health Laboratories (Aeroset, 1998). 
4.2.7. Statistical analysis 
All statistical analyses were carried out using SigmaStat 2.03 (SPSS, 1995). 
4.3. Results 
4.3.1. Plasma levels 
Figure 4.3 shows the changes in the concentrations of plasma metabolite relative to baseline. 
Significant differences (paired t-tests, P<0.05) have been indicated (**). No significant change in 
the concentrations of N,N-dimethylglycine (dmg) or glycine betaine (gb) in the plasma were 
observed. There was a significant increase in plasma trigonelline initially, but no significant 
differences were seen after 3 hours. A significant increase in plasma homocysteine levels was 
observed. Raw data can be found in section 7.4.3. 
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Figure 4.3: Change in plasma metabolite levels after the consumption of coffee. Boxes 
represent interquartile ranges, and error bars represent the 95th percentile. Significant 
differences from the base line (P<O.05) have been marked (**). 
4.3.2. Urine levels 
Total trigonelline ingested was 600 ± 50 ,umol (mean ± SEM), and 230 ± 30 ,umol (38%) was 
recovered in the urine. Figure 4.4 shows the changes in urinary excretion of glycine betaine 'and 
trigonelline. The graphs show the total metabolite (per mol creatinine) before and after coffee 
consumption. Paired t-tests were carried out, and the increased excretion of both compounds 
proved to be significant (P<0.05). 
500 
,.--, 
d) 
Q 
''''; 
.S 
Cd 
~ 400 
] 
--.. 
-0 ! 300 
~ 
0 
'.g 
200 ~ u 
I< 
4.) 
4.) 
i3 
-~ 100 
0 
/;JJj 
'!:: 
""'" 
0 
2404 (lOA) 
.T 
I I 
Before 
336.0 (95.2) ** 
I 
After 
58 
4. Coffee and Homocysteine 
Figure 4.4: Change in betaine excretion after the consumption of coffee. Values 
have been adjusted for creatinine excretion. Means (SEM) are shown, and 
significant differences from the base line are marked (**). 
Before values were taken from analysis of the baseline urine (produced before 9 
am) and the After values were calculated from analyses of all urines produced 
after 10 am). 
4.4. Discussion 
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Plasma homocysteine is a continuous and graded risk factor for cardiovascular disease (CVO) 
(section 1.3), so it is of interest that plasma homocysteine concentrations were increased after the 
acute ingestion of coffee. This result is consistent with the observations of Urgert et a!. (1996) 
that volunteers who drank 1 I of coffee per day for 4 weeks had significantly higher (1.5 /-lmoll- I) 
homocysteine concentrations than when no coffee was consumed. The present study shows an 
increase of c. 1 /-lmoll- I (base line = 9.6 /-lmol!"I), 2 h after coffee consumption. A recent study by 
Olthof et a1. (2001) has shown that chlorogenic acid, also present in coffee, causes a moderate, 
short term increase (1.2 /-lmOn- l ) in plasma homocysteine levels. The concentration of chi orogenic 
acid present in the coffee used in this study was not determined, but can be estimated to be 1 g, 
half the amount of chlorogenic acid given by Olthof et al. and is potentially responsible for the 
increase in homocysteine concentrations seen. 
The increase in trigonelline excretion observed is consistent with previously reported 
observations. The recovery of trigonelline in the urine in the present study (38%) is higher than 
the 20% reported by Yuyama et a1.(1996). This difference may be due to differences in the doses 
that were given: 600 /-lmol (82 mg) in the present study compared with 288 /-lmol (39 mg) given 
by Yuyama et a1. The increased glycine betaine excretion may b~ due to diuresis, caused by 
caffiene and the liquid consumed, but this has not been tested. The change in urinary glycine 
betaine excretion was compared to a previous study (Sizeland, 1995) in which 20 ml/kg body 
weight of water was consumed in 10 minutes (ie, 1.4 I for a 70 kg person). The urine was 
collected for three hours after water was administered, and the glycine betaine excretion increased 
from 6.2 to 16.2 mmoll- I glycine betaine. In the present study, glycine betaine excretion increased 
from 6.1 to 18.2 mmoll- I glycine betaine per mole creatinine (P=0.014). This increase is slightly 
higher than published in the previous paper. Full data from the previous study was not available, 
so a statistical comparison could not be carried out. 
The design of the study had limitations, in that it could not prove if trigonelline in 
coffee causes increased plasma homocysteine concentrations. Ideally, trigonelline would have 
been given directly, and blood and urine samples collected and analysed. This option was 
investigated, but the difficulty of obtaining ethical approval, and also the high cost and difficulty 
in obtaining trigonelline that would be approved tor human consumption meant that it was not 
achievable within the time frame of this thesis. 
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The changes observed in the homocysteine concentrations varied between 
individuals, This suggests that coffee affects plasma homocysteine concentrations differently in 
different people, The differences may be due to many factors, such as protein levels in the diet, 
absorption of trigonelline, current folate status and genetic determinants, All of these factors are 
known to affect plasma homocysteine concentrations, and the effect of coffee observed in this and 
other studies may be dependent on these or other factors. A trial with a much larger number of 
subjects would be required to demonstrate the effect of coffee consumption with these other 
factors, 
4.5. Conclusion 
There is a moderate short term increase in plasma homocysteine associated with the consumption 
of large amounts of coffee, The causal agent(s) of this could not be identified in this study, A 
more controlled experiment, using pure substances, is required to pinpoint the component(s) of 
coffee that are responsible for the observed increase, 
As there is no threshold for the risk of CYD associated with homocysteine, any 
increase in homocysteine has a cumulative effect on the risk ofCYD, The change noted here may 
not be of concern for the individual, but a 10% increase in plasma homocysteine concentrations 
of coffee drinkers may have major implications for the health of a community, 
The observations that both trigonelline and homocysteine are increased in plasma 
is consistent with the hypothesis that trigonelline, a betaine present in coffee, interacts with 
homocysteine metabolism and may be a causal agent in the increased homocysteine concentrations 
associated with coffee consumption, 
Chapter 5 
The Trigonelline Effect 
"If we knew what it was we were doing, it would not be called research, would it?" 
Albert Einstein 
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5.L Background 
Randall (1998) showed that the betaine trigonelline, in the presence of salt, consistently 
exacerbated the urea intolerance of Escherichia coli (ATCC 29522) (Bauer, 1973) in minimal 
media (figure 5.1). The growth rate in the presence of urea (500 mmoll-1 ), salt (300 mmoll-1 ) and 
trigonelline (100,umoll-1) was significantly lower (P<O.OOI) than the growth rate in the presence 
of urea and salt (no trigonelline). This effect was not seen with any other related betaines. The 
mechanism by which trigonelline causes the exacerbation of urea's cytotoxic effect is unknown. 
5.1.1. Betaine accumulation 
Glycine betaine is utilized by E.coli as an osmoprotectant. E.coli is unable to synthesis glycine 
betaine, so specific active transporters exist to accumulate glycine betaine from the environment. 
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Figure 5.1: Growth of coli after 16 hours (3]oC, shaking water bath) in minimal 
media containing urea (0.0 to 1.0 moU-1), salt (0.3 moU-1 NaC!), and different 
betaines (100 ,umoU-1), Taken from Randall (1997). 
63 
5. The Trigonelline Effect 
E.coli has at least three proteins (ProP, ProU and PutP) that transport glycine betaine across the 
membrane. ProP and ProU are osmoregulated, and are responsible for the rapid uptake of glycine 
betaine in hyperosmotic media (reviewed in Randall 1997). These transporters are non-specific, 
being able to transport betaines including arsonium and sulfonium analogues (Peddie et al. 1994; 
Randall et al. 1995; Randall et al. 1996), proline betaine (Peddie et al. 1994), ectoine (Jebber et 
al. 1992), taurine (McLaggan and Epstein 1991) and proline (Wood 1988). 
Mammalian cells also accumulate glycine betaine via a number of transporters. 
Madin Darby Canine Kidney (MDCK) cells transport betaines by osmoregulated and 
non-osmoregulated ports (Wood 1988). These ports are more selective for different betaines than 
the bacterial betaine transport systems. (Randall 1997). In mammals, proline betaine and 
trigonelline are not accumulated in the kidneys (Lever et al. 1 994a). Instead, they are excreted 
into the urine, and glycine betaine is reabsorbed into the blood plasma (Chambers and Lever 
1996). This strongly indicates that transporters in mammalian kidney cells are able to differentiate 
between glycine betaine and other betaines. 
5.1.2. Urinary tract 
Human urine commonly reaches levels of salt and urea that would be inhibitory to coli and other 
common urinary pathogens. Despite this, E. coli can invade and colonize the urinary tract. Urinary 
tract infections (UTI) are a major cause of hospitalization, with 50% of all females and 15% of 
males having at least one symptomatic UTI in their life time (Kunin, 1987). One major mechanism 
by which urinary pathogens are able to overcome the inhibitory nature of urine is via the 
accumulation of glycine betaine as a counteracting solute. Glycine betaine is present in low levels 
in mammalian urine and is an important factor in making the urine a suitable growth medium 
(Chambers and Kunin 1985). 
Conditions in the urinary tract are extremely variable, with the concentration ranging 
from 50 mosmoll- I to 1200 mosmoll- ' (Penney 1987) and urea levels reaching 500 mmoU- 1 
(Asscher 1980). Trigonelline is a dietary betaine (section 2.3.1) and can be found unmetabolized 
in urine at levels of over 10 mmoll- ' (Lever 1994a; Yuyama 1996; section 4.3.2). 
5.1.3. Hypothesis 
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The urinary tract frequently reaches urea and salt concentrations where the trigonelline effect 
would be expected to occur, This led to the hypothesis that dietary trigonelline excreted in the 
urine may inhibit the growth of E.coU (Randall 1997). This could be exploited as a treatment of 
urinary tract infections and reduce the likelihood of recurrence. The plausibility ofthis was studied 
in this section. 
5.2. Methods 
5.2 Growth media and conditions 
5.2.1.1. Minimal media 
The minimal medium of Davis (Davis 1973) was sterilized by passing through a 0.2 ,urn filter 
(Millipore). Other components of minimal media were added as required. Full details can be seen 
in section 7.5.l. These were incubated at 37"C in a shaking water bath. 
5.2.1.2. Urine 
Urines were obtained from volunteers who had abstained from coffee and sprouts (foods known 
to contain trigonelline) for at least 2 days. Urines were tested, and those low in betaines were 
pooled and sterilized. Distilled water, glycine betaine solution and/or trigonelline solutions were 
added to make urines of identical volume and composition except for the betaine content. Full 
details can be seen in section 7.5.2. These were innoculated and incubated at 37°C in a shaking 
water bath. 
5.2.1.3. Innoculum 
An overnight culture of E.coli A TCC 25922 grown in minimal media was used for innoculation 
of all media, The volume of innoculum was 1°/'0 of the final volume, supplying approximately 
lOx 106 cfu/ml. 
5.2.2. Bacterial enumeration 
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Bacterial numbers in minimal media were approximated using formula 5.1 (Randall 1997): Viable 
counts (plated on blood agar) were used for bacterial enumeration in urine. Plates containing 
20-200 cfu were counted. 
N _ 2 
1000000 - 49.1( 00) + 45( 00) 
Formula 5.1: Formula used to approximate viable cell count using light 
absorbance. N: viable count (cfu/ml). 00: absorbance at 620 nm. 
5.2.3. Betaine uptake 
5.2.3.1. Betaine uptake measurement 
The internal betaine content of bacterial cells was measured by washing and separating the cells. 
The ce11s were then resuspended in extraction solvent and sonicated. The resultant solution was 
derivatized and analyzed using the alumina system as described section 2.5. More details can be 
found in the section 7.5.3. 
5.2.3.2. Betaine transfer 
To measure the accumulation of glycine betaine by bacterial cells already loaded with trigonelline, 
the method used by Randall (1997) was used. The cells were grown in media containing 100 
,umoll-1 trigonelline, separated and rinsed with iso-osmotic saline. The cells were then suspended 
in iso-osmotic saline solution containing 100 ,LLmOU- 1 glycine betaine. After five minutes, the cells 
were collected and processed as described in section 5.2.3.1. More details can be found in the 
section 7.5.4. 
5.2.4. Analyses 
66 
5. The Trigonelline Effect 
Trigonelline and glycine betaine concentrations were measured as described in section 2.5. Urea 
concentrations were measured by Canterbury Health Laboratories by urease assay (Abbott,1998). 
Salt concentrations were approximated by subtracting the urea concentration from the osmolality, 
which was measured by freezing-point depression. 
5.3. Results 
Despite using the same strain of E.coli ATCC 25922 and identical growth conditions, the 
trigonelline effect, as described by Randall (1997) was not seen. Trigonelline had no affect in 
minimal media (figures 5.2 - 5.3) or urine (data not shown) supplemented with salt and urea. 
Glycine betaine had a protective effect againsf both salt and urea at all concentrations tested (50 
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Figure 5.2: Graph showing no effect of trigonelline on the growth rate of 
E.coli in the presence of urea (500 mmoU-1 ) and salt (300 mmoU-1 ). Bacteria 
were incubated for 26 hours. Similar graphs were seen after 4, 6, 8 and 10 
hours. Error bars show the standard deviation. 
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moll-I - 1000 molt
'
) in minimal media but supplemental glycine betaine did not offer any 
increased osmoprotection in urine (data not shown). 
In the transfer experiments, the net result was that glycine betaine was accumulated 
quickly if the cells were transferred to a glycine betaine-containing media. No glycine betaine was 
detected in the cells that were harvested prior to transfer to glycine betaine eontaining solutions. 
Trigonelline was seen in all cultures that were incubated in the presence of trigonelline, both 
before and after transfer. 
4. Discussion 
The conditions (media, temperature, source of chemicals, innoculum) were all identical, and the 
cause of the disappearance of the trigonelline effect is unknown. The most likely change is in the 
bacteria used_ The original culture was stored at -40"C, and a subculture was grown and kept at 
4°C. This subculture was replated from a single colony each week. Although it is unlikely, a 
mutant may have arisen, and this mutant may have been chosen, resulting in the subculture being 
a different strain. Another possibility is that the subculture may have been innoculated by an 
aerosol during preparation, resulting in a completely unrelated strain being present. Subsequent 
investigations have revealed that the trigonelline effect is strain dependent, with only three out of 
ten isolates showing the effect (Peddie 2000). Full investigation into this has not been carried out. 
As was expected, no inhibitory effect of trigonelline was seen in urine. 
With the transfer experiments, the concentrations of glycine betaine and trigonelline 
measured are not consistent between replicates, so it is impossible to tell if glycine betaine 
replaces trigonelline, or if glycine betaine is accumulated in conjunction with trigonelline. 
5.5. Conclusion 
The trigonelline effect as noted by Randall (1997) cannot be exploited for the treatment or 
prevention of UTI for two reasons. 
First and foremost, glycine betaine accumulation and trigonelline accumulation 
appear to be competitive, with the Kill of' glycine betaine being much lower than the KlIl of 
trigonelline. If E.co/i is in a medium with both glycine betaine and trigonelline in it the glycine 
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betaine is accumulated first. Trigonelline is accumulated to a similar degree, but only after the 
glycine betaine has been accumulated (Randall, 1997). As glycine betaine is constantly being 
added to urine in the urinary tract, it can be predicted glycine betaine never becomes limiting, so 
very little trigonelline will be accumulated. This applies even if the cell has accumulated 
trigonelline and then is exposed to glycine betaine. Glycine betaine is always found in urines, 
although dilute urines have very low levels. It must be noted that dilute urines also have very low 
levels of trigonelline if any trigonelline is present. Any urine with trigonelline present also has 
glycine betaine, and the glycine betaine present is accumulated to the detriment of trigonelline 
accumulation. 
The second reason for which this claim can be made is that not all strains show the 
trigonelline effect. In fact, half of the clinical strains (strains that were isolated from UTI) tested 
did not show the trigonelline effect (Peddie 2000). 
Chapter 6 
Discussion 
"Questions are what drives science, not answers." 
Robert S. Root-Bernstein 
6.1. Glycine betaine 
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Glycine betaine is emerging as an important metabolite in humans. It plays vital roles as an 
osmolyte and counteracting solute in kidneys, and as a methyl donor in the reaction catalyzed by 
BHMT. Increasingly, it is becoming apparent that glycine betaine is essential for cell volume 
regulation in other tissues also (reviewed in Somero and Yancey 1997). The concentration of 
glycine betaine in blood is homoeostatically controlled about individual set points (Lever et al. 
1994a), and disturbances can be seen in some diseases, including diabetes mellitus (both type 1 
and type 2) and renal disease (Dellow et al. 1999). Supplementation with glycine betaine has been 
shown to have a variety of beneficial effects (reviewed in chapter 1), and no studies reporting an 
adverse effect have been published. In the human body, glycine betaine can be synthesised from 
choline by bacteria or endothelial cells in the gut or by the liver, or it can be absorbed directly 
from the diet (reviewed in chapter 1). 
The data presented in this thesis allows the dietary intake of glycine betaine to be 
estimated at 150-200 mg/day in the average New Zealand diet (section 3.5), most of which comes 
from wheat and flour products. Shellfish, beetroot and spinach are also good sources (tables 
3.3-3.5), but do not contribute significantly to the average New Zealand diet (Cressey 2001). The 
small number of relatively concentrated sources of these glycine betaine means that it is relatively 
simple to increase the intake, and a diet supplying 620mg/day is realistically obtainable (section 
3.5). Choline is present in all foods (as an essential component of biological membranes), and can 
be oxidized to glycine betaine by bacteria in the gut and by the liver (Zeisel 1981). It has been 
estimated that the intake of glycine betaine in the form of choline could be as high as 500 mg/day 
(ZeiseI1994). However this figure is an estimate, and a database of choline content in foods, as 
well as data relating to the absorbance and metabolism of choline is required, to allow evaluation 
of the amount of glycine betaine that is synthesized under various metabolic states. This research 
was recommended by the report to the (USA) Food and Nutrition Board (1999), so this data 
would be expected to be available in the near future. If 0.5 g/day of glycine betaine (synthesized 
from choline) can be achieved, in conjunction with a high glycine betaine diet, a daily intake of 
1 g or more of glycine betaine is not unrealistic. 
Given that a change in physiological markers can be seen with glycine betaine 
supplementation of 2-6 grams per day (re\'eiwed in chapter 1), there is potential that didary 
glycine betaine and choline are sufficiently high to oCbenefit to human health. To evaluate the data 
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presented in this thesis fully, a clinical trial measuring the dose-response of glycine betaine is 
recommended. It is hard to know what would be best used as a marker of adequate glycine 
betaine intake, but homocysteine, vitamin B status, or the dmg/gb ratio could be considered. 
Studies looking at glycine betaine supplementation with folate deficient and non-folate deficient 
subjects are required. There is evidence that the BHMT pathway may act as an "overflow" 
pathway, and be much more active in folate deficient patients. Thus, patients with a functional 
folate deficiency may respond to glycine betaine supplements differently from patients with out 
folate deficiency. 
Although the dietary intakes of betaines are reported here, the bioavailability is 
unknown. How much betaine in the diet is absorbed into the circulatory system? It is probable that 
glycine betaine is absorbed in the gut probably by the non-selective IMINO porter (Stevens 1985), 
and increased blood concentrations can be seen after supplementation. Other betaines that can be 
found in the diet, and are not required in human metabolism, can also be found in blood and urine, 
indicating that they are absorbed (Lever et a1. 1994a). The extent of this is also unknown. It is 
possible that the procedures used in this project (chapter 2) measures betaines that are unavailable 
to humans in the diet, and this needs to be addressed. 
6.2. Other betaines 
This thesis has established that only two betaines, other than glycine betaine, can be found in the 
diet at levels high enough to have potential metabolic effects; proline betaine and trigonelline. 
Coffee is the predominant source of trigonelline, with small amounts coming from legumes 
(section 3.3). Legumes also contribute to proline betaine, but most is obtained from citrus fruit. 
The relatively concentrated sources of these compounds means that it is relatively simple to alter 
their intake (section 3.3). Neither of these betaines are homoeostatically controlled in the body, 
and both are highly variable in the urine and blood (Lever et al. 1994a), A strong correlation 
between plasma glycine betaine concentrations over three years was seen (figure 1.3A), while no 
correlation was seen between plasma proline betaine concentrations over the same time (Lever 
et a1. unpublished data). There is no evidence that either trigonelline or proline betaine have a 
metabolic role in normal human physiology. although trigonelline is a metabolite of nicotine 
(Budavari L 989), Both proline betaine and trigonelline are cleared efficiently tl'om the blood into 
the urine by the kidney, and neither are accumulated by the kidney, unlike glycine betaine, which 
72 
6, Discussion 
is resorbed (fractional clcarance = 2-5%), and is accumulated by cells in the kidney (Sizeland et 
aL 1993). There is a weak association between urinary glycine betaine and urinary proline betaine 
levels (Lever et al. 1994a), implying a metabolic effect of proline betaine in the kidney, Also, 
Dellow et aL (1999) reported a weak (R= -0.28) but significant negative correlation between 
glycine betaine and trigonelline in the plasma, Again, this shows that there is a metabolic 
interaction of some sort between dietary betaines and glycine betaine, Trigonelline may also have 
a slight anti-diabetic effect (AI-Habori and Raman 1998). These strongly suggest that dietary 
betaines do have metabolic effects, The extent ofthese metabolic effects is unknown, and are of 
great interest because of the potential implications for human health. 
There is potential that trigonelline is responsible for the increase in homocysteine 
concentrations seen after consumption of coffee (chapter 4), although 0 lthof et al. (200 1) 
reported that chlorogenic acid, present in coffee, is at least partially responsible for the increase 
in plasma homocysteine concentrations associated with coffee, Another potential cause of the rise 
in homocysteine concentrations after the consumption of coffee is the large increase in urinary 
excretion of glycine betaine reported in this thesis. However, this effect may be due to diuresis, 
caused by the consumption of water (in coffee) and caffeine (a diuretic). Diuresis can also be 
suggested as the mechanism by which diabetics have high plasma homocysteine concentrations. 
Given that proline betaine is a weak substrate for BHMT (Mulligan et a1. 1998) , 
there is the potential for it and other dietary betaines to act as inhibitors in physiological 
conditions. Further studies on purified BHMT are recommended, to see which substances in the 
diet and in the body act as inhibitors or substrates at physiological concentrations. It is common 
for supplementations of glycine betaine or methionine to be given with orange juice, a rich source 
of proline betaine. The observations reported in many studies may in fact be a result of proline 
betaine instead of the compound given, or the effect of these compounds may be altered by 
proline betaine. If studies with purified BHMT show that proline betaine interacts significantly in 
physiological conditions, then a clinical study into the physiological effect of proline betaine is 
recommended. If there proline betaine does affect activity or regulation of BHMT, then the 
conclusions drawn from studies using orange juice as an inert carrier may need to revised. The 
kinetics of other betaines, especially trigonelline. also need to be elucidated. 
There are a number of other betaines that can be found in nature (figure l.l) and 
would be expected to be found in foods. The data presented here shows that the levels of these 
betaines in foods are low, and thus arc unlikely to have any metabolic effects. 
6.3. Conclusion 
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This thesis has laid the foundations for the study of the effect of dietary betaines on human 
metabolism. With the data presented the dietary betaines that are potentially important, and 
foods in which they are present, have been identified. The foods which contain high levels of 
betaines have also been identified, and the relevance of studies supplementing glycine betaine can 
be put into perspective. 
Chapter 7 
Appendix 
"The end is nigh!" 
Unlmown 
7.2. 
7.2.1. 
Chapter 2 
Recovery of dichloromethane extraction 
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A solution containing glycine betaine and trigonelline (1000 ,umoll- I ) was extracted with 
dichloromethane as described in section 2.5.1.5. The dichloromethane layer was separated and 
evaporated at room temperature under a stream ofN2 gas. This was resuspended in 500 ,ul H20. 
The resuspended solution, the original aqueous standard and the extracted aqueous standard were 
derivatized. 
7.2.2. Derivatization reaction at the start of this project 
A 20 ,ul aliquot of sample was added to 1 mi of 10% methanol in acetonitrile. A heaped spatula 
of anhydrous Na2S04 (c. 350 mg) was added, and the mixture was shaken for an hour. The 
mixture was then centrifuged (5 min, 11000 rpm) to remove the Na2S04 and any other solids, 
such as denatured protein. A 250 ,uI aliquot of the supernatant was transferred to a fresh 
microfuge tube. Derivatizing reagent (50 ,uI, 100mmoll-1 2-naphthacyl trifluoromethanesulfonate 
in acetonitrile) was added, and the mixture was shaken for five minutes. Mg(OH)2 solution (5 ,ul, 
O.lg/ml MgO suspended in distilled water) was added, and the solution was shaken for a further 
five minutes. This mixture was then centrifuged (5 min, 11000 rpm) and the supernatant was 
transferred to an HPLC vial for analysis. Vials were capped immediately to stop concentration by 
evaporation. 
7.2.3. Testing of derivatization solvents 
Acetonitrile, 10% methanol in acetonitrile. monoglyme (1 ,2-dimethoxyethane), 5% water in 
monoglyme, diglyme (2-methoxyethyl ether), propan-2-ol, methanol and acetone were tested 
using a standard betaine solution (containing I 111111011- 1 acetyl cami tine, camitine, creatinine, N, N-
dimethylglycine, glycine betaine, trimethylamine, and trigonelline). A 100 ,ul aliquot of the test 
solution was added to I ml of 10% mcthanol in acetonitrile (oncc tor each solvent being tested). 
This was evaporated to dryness at room tel11perature under a stream of N 2 gas. The residue was 
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resuspended in 250,u1 of the appropriate test solvent and was shaken for 15 minutes, ensuring all 
of the betaines were in solution. Derivatization was then carried out as described (2.5.2), llsing 
a derivatizing solution made in acetone instead of acetonitrile. The experiment was also repeated 
with a standard containing 1 mrnoll- I of arsenobetaine, betonicine, butyrobetaine, 
N,N-dimethylglycine, glycine betaine, and trigonelline. These were separated on the Zorbax HPLC 
system as described in section 2.5.3.2. The HPLC traces were compared to show the relative 
efficiencies of derivatization. 
7.2.4. Effect of water on derivatization 
A I mrnoll-1 betaine solution containing acetyl camitine, camitine, creatinine, N,N-dimethylglycine, 
glycine betaine, trimethylamine oxide and trigonelline was derivatized (as described in section 
2.5.2) in acetone containing varying amounts' of water (0,5 and lO% v/v), and the resultant HPLC 
traces were compared. 
7.2.5. Order of reactants 
A sample containing 100 ,umoll" I of acetyl camitine, arsenobetaine, betonicine, butyrobetaine, 
camitine, creatinine, glycine betaine, N,N-dimethylglycine and trigonelline, and a water blank were 
used. Derivatization was carried out in acetone, using 5 ,ul of sample. Derivatizing reagent and 
base were prepared as described in section 2.5.2. In treatment A, base was added, and derivatizing 
reagent was added 5 minutes later. In treatment B, derivatizing reagent was added, and base was 
added five minutes later, and in treatment C, derivatizing reagent and base were added at the same 
time. Each sample was shaken for 5 minutes, and then centrifuged. These were then analysed 
using the Zorbax system, and the chromatograms were compared. 
7.2.6. Phenosphere 
A standard containing 100 pmoll" I each of acetyl camitine, carnitine, glycine betaine, 
N,N-dimethylglycine and trigonellinc was dcrivutized. The samc mobile phase as the Zorbax 
system but with half the buffer conccntration {3.5 mmoU-1 glycolic acid, 7 mmoU- 1 tetramcthyi 
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ammonium hydroxide, 5% water in acetonitrile) was used for the blue trace. The buffer 
concentration was doubled to 7 mmoll- I glycolic acid and 14 mmol1- 1 tetramethyl ammonium 
hydroxide while the water concentration was kept at 5% to increase the elution times. The water 
concentrations was raised to 10% (v/v), resulting in the green trace. 
7.3. Chapter 3 
7.3.1. Foods that had inconsistent chromatography 
7.3.1.1. Apples 
The chromatogram from the Zorbax system gave glycine betaine and trigonelline concentrations 
of 2.5 and 3.4 f-I.g/g respectively. No peakS were seen on the alumina system with the low 
sensitivity detector. Less than 5 f-I.g/g of glycine betaine and trigonelline has been reported. 
7.3.1.2. Avocado 
Proline betaine was measured at 5 f-I.glg using the Zorbax system, but was not seen the other two. 
Less than 1 f-I.g/g has been reported. 
The glycine betaine concentration in avocado was measured at 7.4 f-I.moll- I (Zorbax), 
12 f-I.moll- I (Phenosphere) and46 f-I.moll-I (alumina). These values correspond to concentrations 
of less than 10 f-I.g/g (for Zorbax and Phenosphere) and 16 f-I.g/g (for the alumina). The peak shape 
on the alumina system was distorted, indicating that one or more compounds co~eluted with 
glycine betaine. The difference between the two remaining results is within the error of the assay, 
and less than 10 f-I.glg has been reported. 
Trigonelline was measure at 34 f-I.moll- I (14 f-I.g/g) on the Phenosphere system, but 
was not seen with the other systems. However, the retention time of this peak is 25.5 minutes, 
while the trigonelline standards eluted at 24.5 minutes. The difference in retention times is great 
enough to conclude that the peak is due to another compound. Trigonelline has been reported as 
less than 1 pg/g. 
7.3.1.3. Banana 
The concentration of proline betaine, glycine betaine and trigonelline in the banana extract was 
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9,25 and 95 ,Umon- I respectively. None of these peaks were visible with the low sensitivity UV 
detector. The average of the results from the chromatograms using the good UV have been 
accepted. 
7.3.1.4. Broccoli 
There was significant interference in one chromatogram at the time at which trigonelline would 
run, so no quantification was possible. The other two chromatograms showed no trigonelline 
present, so less than 1 ,Ug/g has been reported. 
The concentration of glycine betaine obtained on the Zorbax system was 7.8 ,Ug/g. 
No glycine betaine was detected in the chromatograms which were recorded with the UV detector 
with lower sensitivity. The concentration of glycine betaine has been reported as less than 10 
,Ug/g. 
7.3.1.5. Brussel Sprouts 
The trigonelline values obtained range from 28 to 93 ,Ug/g in brussel sprouts. The values from the 
alumina system have been accepted, because they are consistent and lower than the Phenosphere 
values. The trigonelline peak on one of the alumina chromatograms was asymmetrical and was 
ignored, although the peak height was consistent with the other chromatograms. 
7.3.1.6. Cauliflower 
Trigonelline was unquantifiable in one system due to interference. Only the values form the other 
system were used. 
73.1.7. Cheese 
The cheese extract showed a very large glycine betaine peak, corresponding to over 2000 ,umoll" I , 
on the alumina system. No peak of that size was seen anywhere on the Phenosphere system. This 
indicates that the compound either eluted early on the Phenosphere, or it was retained on the 
column. If the first applies, then the compound would elute in the initial peak, so would not be 
detected. If the compound was retained on the column, then it may appear during latter 
chromatograms, or it may be retained on tbe column indefinitely. Evidence of either of these 
scenarios was not seen. No investigations were c:.llTied out to identify the compound. Since the 
79 
7. Appendix 
peak was not seen on the Phenosphere system, the level of glycine betaine in cheese has been 
reported as less than 1 I1g/g. 
7.3.1.8. Cod 
Arsenobetaine was detected in about half ofthe chromatograms, at levels up to 25 I1g/g, but no 
arsenobetaine was detected in the remaining chromatograms and no arsenobetaine has been 
reported. 
Proline betaine was detected using the Zorbax system at 38 I1g/g, but in the other 
eight chromatograms less than 5 I1g/g was detected. This value has been reported. 
Trigonelline was detected using the alumina system, but was not observed using the 
other systems, so less than I I1g/g has been reported. 
7.3.1.9. Groper 
Proline betaine was detected in three chromatograms (9, 50 and 228 I1moll-I), but was not seen 
in the remaining three chromatograms. Less than 1 l1g/g has been reported. 
Glycine betaine was quantifiable in three of the samples, but there was interference 
in the remaining three samples. The value reported is the mean of three concentrations. 
Two large peaks were detected on two of the chromatograms. One of these has a 
retention time that is different from any ofthe known betaine derivatives. No further investigation 
was made. The other peak has a retention time corresponding to ergothionine, but this was only 
seen on the alumina system. No peak corresponding to ergothionine was detected on the 
Phenosphere system. No ergothionine has been reported, and no further investigation of these 
compounds were made. 
7.3.1.10. Gurnard 
Proline betaine was detected in one system, at a concentration of 11I1moll-l, corresponding to a 
concentration of 4.5 I1g/g. No proline betaine was detected on the other systems, and has been 
rep011ed as less than I I1g/g. 
Glycine betaine was detected at four different levels. Using the Zorbax system, the 
glycine betaine concentration was measured at 90 and 1550,ug/g. The alumina system gave a 
result of 6.0 /-<g/g, and glycinc betaine was not detected using the Phenospherc system. The 
glycine betaine concentration was reported as less than [O/-Lg/g. 
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Trigonelline was detected at a concentration of 65 pg/g in one chromatogram, but 
no trigonelline was detected in the other chromatograms. This was reported as less than 1 pg/g 
A small amount (4.l, 5.8, 18.7 pmoU-') of arsenobetaine was detected in three 
different systems, corresponding to between 2 and 10 pg/g. This was reported as less than 10 
pg/g. 
7.3.1.11. Kiwifruit 
The values for proline betaine and glycine betaine were 0.7 and 4.6 pg/g respectively in one 
system. The other system did not detect any betaines, but was recorded using the UV detector 
with low sensitivity. The concentration of these betaines has been reported as less than 1 and less 
than 5 pg/g respectively. 
7.3.1.12. Kumara 
A substantial amount of interference occured on one chromatogram. The remammg 
chromatograms gave consistent results, and the mean of these has been accepted. 
7.3.1.13. Leek 
Glycine betaine was detected at 0.6 jJ.g/g in one system, and was not detected in the other 
systems. Glycine betaine in leek has been reported as less than 1 pg/g. 
The concentration of proline betaine detected on the alumina was 2.9 pg/g, and no 
proline betaine was observed using the Phenosphere system. The proline betaine concentration 
has been reported as less than 1 pg/g. 
7.3.1.14. Lettuce 
The lettuce sample on the alumina system gave a glycine betaine and a trigonelline concentration 
of 7.5 and 4.9 jJ.g/g. Neither were detected on the Phenosphere system, and are reported as less 
than 1 
On the Phenosphere system, a peak corresponding to arsenobetaine was seen. The peak was very 
smalL and no arsenobetaine was detected using the alumina system. No arsenobetaine has been 
reported. 
7.3.1.15. Marmite 
8] 
7. Appendix 
A high level (14.3 f..lg/g) of arsenobetaine was detected in one derivatization when assayed on the 
alumina system. Repeats on the alumina system and on the Phenosphere system yielded no 
detectable arsenobetaine present. It can be assumed that there was a problem with that particular 
derivatization, highlighting the impOl1ance of repeating samples and injections on the HPLC. No 
arsenobetaine has been reported. 
Proline betaine was detected at concentrations up to 9.8 f..lg/g in some 
chromatograms, but was undetectable on other chromatograms. This has been reported as less 
than 1 f..lg/g. 
Glycine betaine was detected at concentrations ranging from 4.4 to 9.1 f..lg/g, except 
for one chromatogram that showed a glycine betaine concentration of 60 f..lg/g. It was assumed 
that this result was due to interference, so less than 10 f..lg/g has been reported. 
Trigonelline was not present in all ofthe chromatograms except one. That result was 
73.7 f..lmolt' (12 f..lg/g), but this is likely to be due to interference. The value reported is less than 
1 f..lg/g. 
7.3.1.16. Mushroom 
The results from three different systems gave very similar results (c. 23 f..lg/g) for glycine betaine. 
Repeats ofthe mushroom extract were made, yielding undetectable levels of glycine betaine. This 
discrepancy cannot be readily explained. Less than 10 f..lg/g has been reported. 
7.3.1.17. Onion 
Both glycine betaine and proline betaine were detected at a low levels, but were not seen when 
the low-sensitivity detector was used. Both have been reported at less than 5 J-tglg. 
7.3.1.18. Parsnip 
Proline betaine and glycine betaine were detected at 2.6 and 4.5 f..lg/g respectively on the Zorbax 
system. These were not detected on other systems with the low-sensitivity detector, and have both 
been repor1ed as less than 5 pg/g. 
7.3.1.19. Pepper 
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A high arsenobetaine concentration was detected using the Phenosphere system, but a repeat of 
this on the same system showed no arsenobetaine. None ofthe other chromatograms showed any 
arsenobetaine, and none has been reported. 
Glycine betaine was also detected in some systems at low levels, but were not 
detected in other systems. These were all below 10 ,ug/g, and this value has been reported. 
7.3.1.20. Plum 
Small amounts of glycine betaine were detected in some chromatograms, but none was seen in 
the others. These peaks correspond to a concentration of less than 5 ,ug/g so have been reported 
as that. 
Trigonelline was detected on one chromatogram (22 ,umoU-1, 2.8 ,ug/g), was not 
detected in the other chromatograms, including a repeat on the same system. The trigonelline 
concentration has been reported as less than 1 ,ug/g. 
Proline betaine was detected at low levels (c. 10 ,umoU'\ 1.3 ,ug/g) in some 
chromatograms, but none was seen in others. This has been reported as less than 1 /-tg/g. 
7.3.1.21. Potato 
A small amount of glycine betaine was seen in two different systems. There was a considerable 
difference in the values (18 and 38 ,umoU· 1), but both ofthese correspond to concentrations ofless 
than 10 ,ug/g in potato, so that has been reported. 
7.3.1.22. Perch 
Aisenobetaine was detectcd at 5.6 and 10.1 ,umoll- I (2.4 and 4.3 ,ug/g) using the Zorbax system, 
but was not dctcctcd in alumina or Phcnosphere systems. This has been reported as less than 5 
Proline betaine was detected at I and 61 using the Zorbax system but was not 
detected in either the alumina or Phenosphere systems. This has been rcported as lcss than l,ug/g. 
Glycine betaine was detected at three different levels. Using the Zorbax system, the 
glycine betaine concentration of was recorded at 360 and 8750 /-lmoll- I (100 and 2440 ,ug/g). The 
alumina system gave a result 01'93 ,Umol1- 1 (26 {Ig/g). There was a peak corresponding to glycine 
betaine detected on the Phenospilcrc system, but this was 1Il1quantitiable. The result from the 
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alumina system was accepted, and the glycine betaine concentration has been reported as 261J-g/g. 
Trigonelline was detected in one of the Zorbax chromatograms, but was absent from 
the remaining three chromatograms, so has been reported as less than I IJ-g/g. 
7.3.1.23. Salmon 
Arsenobetaine was detected at levels up to 25 IJ-molt' (up to 15 IJ-g/g) using the Phenosphere 
system, but no arsenobetaine was observed using the alumina system. This has been reported as 
less than IIJ-g/g. 
Proline betaine was observed in one chromatograms using the Phenosphere system, 
and on one chromatogram using the alumina system. These chromatograms were from the same 
derivatization. The values obtained were 40 and 27 IJ-moll' , (18 and 121J-g/g) respectively. Proline 
betaine was not detected in repeats using the same systems, so it appears that the peaks observed 
were artifacts from that derivatization. The proline betaine concentration has been reported as less 
than 1 IJ-g/g. 
The glycine betaine peaks on three of the chromatograms were asymmetric, 
suggesting that another compound co-eluted with it. The remaining four chromatograms gave 
consistent glycine betaine concentrations, and the mean of these values has been reported. 
Trigonelline was detected in one chromatogram, at a level of 50 IJ-moll" , (22 IJ-g/g) , 
but was absent in the other six chromatograms. This has been reported as than 1 IJ-g/g. 
7.3.1.24. Soy sauce 
Proline betaine was detected at levels between 15.9 and 3 7.llJ-moll" (2.3 and 5.3IJ-g/g). This has 
been reported as less than 5 IJ-g/g. 
7.3.1.25. Teraldhi 
Arsenobetaine was detected at 13, 6 and 10 IJ-g/g. The concentration reported is the mean of these 
values. 
Proline betaine was detected on one chromatogram (IO ,umoU-', 3 AlJ-g/g), but not 
in the other three chromatograms, This has been reported as less than I /--lg/g. 
The glycine betaine concentrations range from 1.4 to 28 ,ug/g. The chromatograms 
recorded on the alumina and Zorbax, give similar results ( 1.4 and 3 IJ-g/g), and less than 5 ,ug/g 
has been reported. 
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Trigonelline was detected at 13, 6, and 0 p,g/g. These data are consistent with a 
coeluting compound on the Zorbax system. The trigonelline concentration has been reported as 
less than 1 p,g/g. 
7.3.1.26. Tuna 
In four of the chromatograms, the values ofarsenobetaine ranged between 1.7 and 2.5 p,g/g. The 
remaining two chromatograms have interfering peaks at this time, and were unquantifiable. The 
arsenobetaine concentration has been reported as less than 5 p,g/g. 
Proline betaine was observed in one chromatogram, at a concentration of 4.6 p,g/g, 
but was not detected in any of the remaining five chromatograms. This has been reported as less 
than I p,g/g. 
Glycine betaine was detected in all systems. The four chromatograms also gave 
differing results. ThePhenosphere chromatograms gave results on.7 and 7.8 p,g/g, where as the 
results from the alumina chromatograms were 36 and 28 p,g/g. It is most likely that the glycine 
betaine derivative coelutes with something else on the alumina system, and the Phenosphere 
results were accepted. This has been reported as less than 10 p,g/g. 
7.3.1.27. Vegemite 
The chromatograms ofVegemite extracts were virtually identical to those of Mannite. 
Proline betaine was detected in high quantities in some chromatograms, but was not 
detectable in others, so less than 1 p,g/g has been reported. 
Glycine betaine was measured in concentrations ranging from 1.9 to 11 p,g/ g, except 
for one chromatogram which gave a concentration of 87 p,g/g. The value reported is less than 10 
p,g/g. 
Trigonelline was not detected in seven of the chromatograms, but was detected at 
a high concentration (140 .umol!"', 21 p,g/g) in one chromatogram. This is assumed to be 
contamination, and the trigonelline concentration has been reported as less than 1 p,g/g. 
7.3.1.28. Wine 
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The trigonelline peak on the alumina system is symmetrical, but the trigonelline peak on the 
Phenosphere system is asymmetric, indicating coelution of another compound. The height of the 
peak on the Phenosphere chromatogram is consistent with the alumina system result, and the 
value obtained with the alumina system has been accepted. 
7.3.1.29. Yam 
The yam extract was assayed with both the Phenosphere and the alumina system twice. This gave 
three different results for the trigonelline content (0, 20 and 50 ,umoo-'). These all correspond to 
a concentration of less than 10 ,ug/g, so this has been reported. 
Glycine betaine was recorded at four different concentrations ranging from 4 to 38 
,umolt'. All of these correspond to less than 10 ,ug/g, so this has been reported. 
A peak corresponding to arsen~betaine was detected in one run on the Phenosphere 
system, but this was not seen on either the Phenosphere or the alumina column. No arsenobetaine 
has been reported. 
7.3.2. 
Breakfast 
Morning tea 
High betaine diet 
Porridge (30 goats, 500 ml milk) 
Grapefruit, one (236 g) 
Bread, one thick slice (40 g, assume flour 75 %) 
Margarinelbutter (lOg) 
Marmite (0.5 tsp, 3.25 g) 
Tea (180 ml, with 30 ml milk) 
Orange, one (128 g) 
Bread, wholegrain, two medium slices (56 g, assume flour 75%) 
Margarinelbutter (25 g) 
Lettuce leaves, two (16 g) 
Tomato, one (127 g) 
Tuna (90g) 
Beetroot (60 g) 
Muffin (80 g, assume flour = 25 %) 
Tangelo, one (90 g) 
Yoghurt (150 g) 
Orang~ juice (250 ml) 
Afternoon tea 
Dinner 
Supper 
Tea (180 ml, with 30 ml milk) 
Wine biscuits, two (16 g, assume 80 % flour) 
Pasta (300 g) 
Mussels (110 g) 
Tomato Sauce (125ml) 
Spinach (84 g) 
Cheese (25 g) 
Crackers, four (18 g, assume 90%) flour) 
Coffee (180 ml, with 30 ml milk) 
Bread, one thin slice (28 g, assume flour 75 %) 
Mam1ite (0.5 tsp, 3.25 g) 
Milo (5g milo, 30 ml milk) 
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7.4. 
7.4.1. 
Chapter 4 
The consent form for the coffee trial 
Consent Form 
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Can coffee and bean sprouts combat bacteria in the urinary tract and 
increase the risk of cardiovascular disease? 
I have read and understood the infonnation sheet dated 2nd November 1998 for volunteers 
taking part in the study designed to see whether the consumption of food or drink 
containing the compounds trigonelline and/or proline betaine would produce urine which 
inhibited the growth of bacteria and also to discover the achievable levels of these 
compounds and of homocysteine and dimethylglycine in plasma and urine. I have had the 
opportunity to discuss this study and I am satisfied with the answers I have been given. 
I understand that taking part in this study is'my own choice. I may withdraw at any time and 
this will not affect my future health care in any way. 
I understand that my participation in this study is confidential and that no material which 
would identifY me will be used in any reports on the study. 
I understand the ACC compensation provisions for this study. 
I have had time to consider whether to take part. 
I know who to contact if! have any side effects to the study, or if! have any questions 
about the foodstuffs being used in the study. 
I consent to the researchers storing specimens of my blood and urine for their later use as a 
part of this study. YESINO 
I wish to receive a copy of the results YESINO 
_______________ (full name) hereby consent to take part in this 
study. 
Date _____ _ 
Signature 
7.4.2. Information sheet for the coffee trial 
INFORMATION SHEET 
2nd November 1998 
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Can coffee and bean sprouts combat bacteria in the urinary tract and 
increase the risk of cardiovascular disease? 
Principal Investigator: Dr Barbara A Peddie, Scientific Officer, Department of 
Nephrology, Christchurch HospitaL 
Phone: 364 0617 (or 364 0640 ext 80617) 
Introduction 
You are invited to take part in a study which will measure the amounts of certain chemical 
compounds which appear in urine and blood ,after consumption of certain foods or liquids. We 
will be looking for eight to ten volunteers. Please read this information sheet carefully and take 
all the time you require to decide whether to take part. 
THE STUDY 
A) Urinary tract infections (UTI) are common causes of consultations in general practice and 
hospital admissions. In the younger age group, women have more uncomplicated UTI. The 
infection rate is higher for Polynesian than Caucasian women. As age increases, the infection rate 
in males rises, and lITI are a significant cause of illness in the elderly popUlation. Urine itself can 
inhibit bacterial growth. This phenomenon is variable and incompletely understood. Urea is 
thought to be urine's principal antibacterial component, its effects augmented by concentrated 
and acidic urines. Our work with betaines suggests that trigonelline, which is abundant in the 
diet (especially in coffee and legumes), may also playa role in concentrated urine (usually the 
first morning urine), Escherichia coli, the major urinary tract pathogen, accumulates betaines, 
including trigonelline. Trigonelline, unlike other betaines tested, exacerbates the toxic effects of 
urea. This project aims to establish the conditions in which this property might be used in 
treating UTI and whether this may explain some of the antibacterial properties ofurine. 
Antibacterial effects of trigonelline will be determined over a range of physiological conditions 
found in the urinary tract and in the presence of other naturally-occurring betaines like glycine 
betaine and proline betaine. 
B) In addition, there has been recent data indicating that in diabetic patients, the plasma levels of 
the compound homocysteine are affected by the amount of glycine betaine and possibly also of 
trigonelline. We wish to see whether this interrelationship also occurs in healthy individuals and 
we propose to collect blood samples to measure tbe above betaines, homocysteine and 
dimethylglycine. Homocysteine is known to be an independent risk factor for cardiovascular 
disease. 
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Eight to ten people will be asked to take part in the study. They will be selected by the 
researchers. No-one who is not already a coffee drinker will be considered for the study; nor 
will anyone who feels that to go for a week without coffee is a great hardship! 
The range of achievable levels of trigonelline and proline betaine will be measured in urine and 
blood following ingestion of foods containing these compounds. Homocysteine and 
dimethylglycine will also be measured. Baseline low levels will be established by restricting 
participants to a diet free of foods known to contain high levels of trigonelline and proline 
betaine for 5 days. Participants will then be given coffee (four cups) over one hour. Urine and 
blood samples will be collected immediately before ingestion of the food to establish baseline 
levels. Three blood samples will be taken before ingestion, and eight hourly samples will be 
taken after ingestion. Each blood sample will be 5 mL Urine will be sampled hourly as the 
participants are able. 
Antibacterial activity will be determined by measuring the growth ofE coli in the urines, using 
optical density. 
2 
To obtain the blood samples, a heparinized catheter will be inserted into the participant's arm 
for the day. Blood will be taken by Dr Steve Chambers or by a registered nurse. All work on the 
blood and urine samples will be done either in the Clinical Pathology Laboratory of the 
Nephrology Department, or in the Biochemistry Laboratory, Canterbury Health Laboratories. 
The entire study should be completed within one year, although the work done with volunteers' 
urine and blood samples is not expected to occupy more than half of that allotted time. 
Time involved: The entire study will involve the participants for one working day. Participants 
will spend the day in a clinic room in Christchurch HospitaL Food, entertainment and 
refreshments will be supplied. The participants will be asked to report on the following day for a 
final blood and urine sample. 
Samples: All urines will be midstream urines. These are collected by letting the first few mls of 
the stream go (in order to flush out skin bacteria) and then passing urine into the container 
provided. For the study measuring the rates of excretion of the test substances, one early 
morning urine and eight hourly samples will be collected for each of the four test substances. 
Blood samples will be drawn from an indwelling heparinized catheter. 5 ml of blood will be 
drawn each time (total of 55 ml). 
RISKS AND BENEFITS 
L Risks and/or inconveniences. 
There may be some risk that a true coffee addict may suffer withdrawal symptoms (headache). 
If you can't start the day without your coffee 'fix' please don't volunteer for this study. 
2. Benefits. 
This is a scientific study and there are no direct benefits to the subjects taking part. 
3. Therapeutic or non-therapeutic? 
This study will measure the levels of certain chemicals which appear in urine and blood after 
eating or drinking certain substances. These mayor may not prove to have activity against 
bacterial infections in urine or to have some implication in modifying homocysteine levels. This 
is not a study in which these substances will be llsed to treat any infection in the participants. 
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In the event that a preliminary baseline urine shows infection, the person will not be used further 
in the study but will be advised to seek treatment from their GP in the regular way. 
4. Costs and/or payments. 
There will be no cost to any participant other than time given in collecting samples. Payment of 
$50 to cover any inconvenience is to be offered to each participant. All food and refreshments 
required will be supplied by the researchers. 
PARTICIPATION 
Your participation is entirely voluntary. You do not have to take part in this study, and whether 
or not you do it will make no difference to any future care or treatment. If you do. choose to take 
part, you are free to withdraw from the study at any time and you do not have to give any reasons 
for doing so. If you do withdraw, again it will make no difference to any future care or treatment 
you may need. If any harmful effects appear, the researcher will stop your participation in the 
study immediately. 
GENERAL 
At the end of the study, all the results from your urine and blood samples will be available to 
you, and you are welcome to talk to the researchers about the project at any time. 
If you have any questions about the study, you are invited to contact the researchers at any time. 
If you have any queries or concerns about your rights as a participant in this study, you may wish 
to contact a Health and Disability Services Consumer Advocate, telephone 3777 50 I 
CONFIDENTIALITY 
No material which could possibly identify you will be used in any reports on this study. Records 
of work done will be kept in the Laboratory workbooks which are only available to the 
researchers and all samples will be coded (by number, not by name). 
RESULTS 
The results of this work will be published in one of the scientific journals, and participants will 
be sent a summary of results if they wish. 
COlVIPENSA TION 
In the unlikely event of a physical injury as a result of your participation in this study, you will be 
covered by the accident compensation legislation with its limitations. If you have any questions 
about ACC please feel free to ask the researcher for more information before you agree to take 
part in this trial. 
7.4.3 Raw data from the coffee trial 
. 
Time Subject 
(hrs:mins) A B 
I 0 E F G H I J 
I 
-0:40 9.9 6.7, 4.4 11=1~r 7.01 7.3 11.4 -0:20 9.4 6.3 7.0 8 .7 7.6 7.3 11.2 0:00 8.41 5.9 5.91 10.11 8 .8 7.6 6.6 11. f 1 :00 9.1 6.3 7.3 10.5 7.5 20.2 7.8 11.8 
2:00 10.0 6.5 6.7 10.8 9.6 7.5 11.9 
3:00 9.9 6.5 6.9 10.4 8.7' 20.6 7.9 12.0: 
4:00 10.0! 6.3 6.91 9.71 9.5 7.1 11.81 
5:00 9.8 6.8 6.7 10 9.1 18.8 7.7 11.6 
6:00 9.6 6.6 7.0 10.1 9.6 7.1 11.6 
7:00 9.4 6.3 6.7 9.2, 7.9 20 7.2 11.51 
8:00 10.2 6.5 9.9 8.9 11.51 
Table 7.1: Raw plasma homocysteine results. All values are in 
,umoW1• Coffee was consumed between Time 0:00 and Time 1 :00. 
Time Subject 
(hrs:mins) A B 0 E F G H I 
• 
J 
-0:40 31.7 53.7 109 79.2 77.2 : 42 42 43.5 I 43.4 1 
-0:20 21.4 56.1 123 I 83.1 70.5 40.6 61 53.8 40.7 
0:00 24.4 64 102 91 170.7 45.9 68.1 186.6 40.2 
1 :00 26.5 74.9 99 82.1 77.4 44.3 ·45.8 73.9 38.9 
2:00 26.8 59.5 107 82.1 82.4 63.2 48.4 58.8 146.3 : 
3:00 28.8 67.9 I 102 : 72.9 , 67 58.8 52_ 
4:00 36.9 56.7 114 .72.9 75.3 51.1 46.8 .6 I 
40.7 6.8 122 175.7 165.2 64.1 44.3 67.4 51.1 
6:00 34.4 : 6.6 101 84.8 80.1 53.5 44.1 54.8 56.5 
7:00 38.8 6.3 122 67.7 59.2 47.1 41.8 7.2 155.6 
8:00 45.1 6.5 72.4 67.2 39.8 65.3 46.8 
Table 7.2: Raw plasma glycine betaine results. All values are in 
,umoIl"1. Coffee was consumed between Time 0:00 and Time 1 :00. 
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Time 
A 
29.8 
16 
24.7 
15.5 
27.6 
20.3 
18.4 
24.1 
22.8 
19.9 
19.1 
Subject 
E F 
29.8 15.3 20.3 
B D 
18.4 16.9 18.9 
20.2 25.5 27.3 
29.1 22.5 I 25.3 • 
26.6 • 16.8 18.9 
28.2 21.6 18.1 
30.9 13.6 22.6 
23.1 22.9 15.4 
26.1 19.5 18.4 
20.1 14.3 22.7 
22.8 19.1 
J 
Table 7.3: Raw plasma trigonelline results. All values are in 
.umoW1. Coffee was consumed between Time 0:00 and Time 1 :00. 
Time Subject 
. (hrs:rnins) A B D E F G H I J 
-0:40 4 5.4 0.7 ! 2.5 4.3 3.7 2.1 5.1 5.1 
-0:20 2 2.8 3.7 4.2 4.2 0.9 1.9 1.8 0.0 
0:00 2.9 4.3 0 3.5 6.2 3.4 4.4 0.2 5.6 
1:00 3.3 2.9 3.4 2 3.3 2.8 2.3 14.0 5.2 
2;00 2.7 1.5 1.7 1.6 6.3 3.9 5 5.9 5.2 
3:00wn .:::1 2.7 3.1 7.2 4.3 10.2 4.9 
4:00 8 3.6 6.6 3.1 3.1 6.5 2.6 4.2 
5:00 6.4 4.2 1.5 4.7 2.5 6.9 4.9 3.5 4.9 
6:00 4.2 1.5 1.7 1.5 5.5 2.9 4.4 8.2 4.5 
7:00 3.5 2.8 1.4 4.1 5.2 3.4 3.2 4.8 4.2 
8:00 3.7 3.3 5.2 1.7 3.5 10.1 7.0 
Table 7.4: Raw plasma N,N-dimethylglycine results. All values are 
in .umoU-1• Coffee was consumed between Time 0:00 and Time 
'1:00. 
Time GB Trig Creatinine Volume I 
(hr:min) , (,umoU-1) (/.-lmoW1) (mmoWl) (ml) 
-0:55 8.4 
·0:20 17.0 1.0 8.6 40 
1 :40 12.5 1.0 0.1 1000 
2:07 5,5 150.1 0.1 480 
4:27 26.1 587 2.8 205 
6:45 20.0 
• 
201.6 5.6 135 
Table 7.5: Raw urine data, subject A 
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Time GB Trig Creatinine 
(hr:min) (,umoll"1) (,umoIl"1 ) (mmoll"1 ) 
-0:48 30.8 473.6 11.1 
-0:05 33.3 504.6 10.0 
1 :50 12.1 166.4 0.7 
2:25 21.7 538.0 2.4 
7:05 13.5 381.9 6.8 
Table 7.6: Raw urine data, subject B 
Time GB Trig Creatinine 
(hr:min) (,umoIl"1 ) (,umoIl"1 ) (mmoIl"1) 
-0:05 4.6 1.0 4.7 
2:05 16.3 36.0 0.3 
3:15 15.0 147.3 0.1 
4:50 24.4 266.4 0.4 
7:10 20.5 287.5 1.0 
Table 7.7: Raw urine data, subject 0 
Time GB Trig Creatinine 
(hr:min) (,umoW1 ) (,umoIl"1 ) (mmoIl"1) 
-0:02 46.5 71.1 16.1 
2:20 20.3 65.7 1.9 
4:15 25.1 480.2 3.8 
6:47 24.4 356.2 3.3 
Table 7.8: Raw urine data, subject E 
Time GB Trig Creatinine 
(hr:rnin) (,umoll-1) (,umoIl"1 ) (mI1101l"1) 
0:22 13.9 10.0 7.2 
2:10 18.2 36.3 1.2 
4:10 9.3 214.4 0.8 
8:03 6.5 224.0 0.8 
Table 7.9: Raw urine data, subject F 
Time GB Trig Creatinine 
(hr:min) (,umoW1 ) (,umoW1 ) (mmoll"1 
-0:02 11.9 35.6 4.2 
3:20 3.2 122.2 0.1 
6:23 8.2 256.4 0.7 
7:55 5.3 120.3 0.1 
Table 7.10: Raw urine data, subject G 
Volume 
(ml) 
40 
20 
500 
90 
300 
Volume 
(ml) 
na 
na 
670 
430 
450 
Volume 
(ml) 
28 
280 
210 
244 
Volume 
(ml) 
na 
420 
450 
540 
Volume 
(ml) 
182 
700 
556 
578 
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Time GB Trig Creatinine 
(hr:min) (,umoU- 1) (~moll·l) (mmoll-1) 
-0:10 14.9 52.8 1.0 
0:45 6.7 17.3 0.1 
1 :53 6.3 22.7 0.1 
2:35 3.3 19.7 0.2 
! 3:40 4.0 95.0 0.1 
~4:50 6.2 88.9 0.1 6:10 I 0.1 94.7 0,1 
7:22 0,1 107,9 0.1 
Table 7.11: Raw urine data, subject H 
Time GB Trig Creatinine 
(hr:min) (,umoil"l) (~moWl) (mmoIl"1) 
-0:15 39.1 76.6 4.9 
2:25 1.0 97.7 0.2 
4:30 20.6 244.9 0.2 
5:42 1.0 49.5 0.2 
7:03 7.2 95.6 0.6 
Table 7.12: Raw urine data, subject I 
Time GB Trig Creatinine 
(hr:min) (flmoU-1) (umoU-1) (mmoIi"1) 
0:13 61.8 76.9 I 8.2 
2:45 10.1 63,4 4,0 I 
4:15 16. 195.5 6.1 
5:55 34,4 310,4 1.2 
Table 7.13: Raw urine data, subject J 
Volume 
(ml) 
250 
380 
790 
576 
455 J 
520 I 
325 
608 
Volume 
(ml) 
68 
530 
330 
495 
560 
Volume 
(ml) 
82 
200 
102 
130 
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7.5. 
7.5.1. 
Chapter 5 
Minimal media 
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The minimal medium of Davis (Davis, 1973) consisting ofKJiP04 (7 g), KH2P04 (3 g), sodium 
citrate (0.5 g), (NH4)2S04 (l g), MgS04 (0.1 g) and 2,9 g of glucose made up to one litre 
(osmolality = 175 mosmollkg), and neutralized (PH 7) with dropwise addition of 1 M NaOH 
or Hel as required was used, This was sterilized by passing through a 0.2 ,umfilter (Millipore). 
Other components of minimal media were added as required, The addition of filter-sterilized urea 
or NaCI to the solution was done volumetrica1ly, Filter sterilized glycine betaine and trigonelline 
standards (10 mmoll- I) were and added to make the desired solution, 
7.5.2. Urine 
Urines were obtained from volunteers who had abstained from coffee and sprouts (foods known 
to contain trigonelline) for at least 2 days. These were filter sterilized, and betaine content was 
analysed, Urines with detectable levels of trigonelline were discarded, as were urines containing 
> 1 0 ,umol!"1 glycine betaine. Urines were pooled to ensure identical growth conditions. Disti1led 
water, 10 mmoU-1 glycine betaine and 10 mmoll- I trigonelline (all filter sterilized) were added to 
make urines of identical volume and composition except for the betaine content. The glycine 
betaine and trigonelline additions ranged from 0 to 1000,umoltl. 
7.5.3. Betaine uptake measurement 
An overnight culture (10 ml) was centrifuged (15 min @ 3000 rpm), and the pellet was washed 
with isotonic solution (containing either NaCI of NaCl and urea depending on the growth 
medium), This w'as centrifuged, and the sllpematant was removed, The pellet was resuspended 
in 2 ml of 10% methanol in acetonitrile and sonicated (5 min), This solution was then derivatized 
(section 2,5.2) analysed using the alumina system (section 2.5.3.2). 
7.5.4. Betaine transfer 
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To test the accumulation of glycine betaine when cells were already loaded with trigonelline, 20 
ml ofovemight culture (with trigonelline) was passed through a 0.45,Um filter (Millipore). Iso-
osmotic NaCl (or NaCl/urea) solution (5 ml) was passed through the filter to wash the cells. The 
cells were washed off the filter using 20 ml iso-osmotic NaCl (or NaCl/urea) solution containing 
100 ,UmoU- 1 glycine betaine. After 5 minutes, the cells were collected and processed as described 
in section 5.2.3.1. 
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